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Introduction 
Benign prostatic hyperplasia (BPH) is a common condition in men over 40 
years of age of all races and cultures [1]. It is known that prostatic hyperplasia is 
identifiable in approximately 50% of men at the age of 60 and in nearly 100% of men 
by the age of 80 [2]. Although the histological prevalence of a disease cannot be 
equated with its associated clinical picture, nevertheless up to three quarters of men over 
the age of 50 will suffer symptoms attributable to BPH. On the other hand, the exact 
incidence is difficult to determine, but it has been estimated that 85% of males will 
develop detectable prostatic enlargement during their life [3]. T. Hald, with his "rings," 
has provided a sound concept in which the pathophysiology is divided into three parts: 
lower urinary tract symptoms (LUTS), prostatic size (enlargement) and bladder outlet 
obstruction (BOO) [41 (figure 1). Despite its traditional relationship to BPH, LUTS are 
not always linked to BOO. It has been demonstrated that 25-33% of patients with 
LUTS and palpable BPH have unobstructed micturition [5]. However, BPH is the most 
common cause of bladder outlet obstruction in elderly men. Because the etiology of 
BPH is still unknown, we lack essential information about mechanisms by which it 
alters voiding functions, and about definitive diagnostic criteria to establish its role in 
pathologic changes and symptom complexes of the urinary tract [6]. Partly therefore the 
diagnosis of BPH is often one of assumption rather than rigorous proof, and this may 
be reflected in the less than perfect outcomes of treatments in recent studies [7]. In 
general the treatment options include transurethral resection (TURP) [8], which 
represents the "gold standard" of treatment, that has been challenged by transurethral 
bladder neck incision (TUIP) [9], transurethral needle ablation of the prostate using a 
radiofrequency device (TUNA) [10], transurethral microwave thermotherapy (TUMT) 
[11], high intensity focused ultrasound (HIFU) [12], several laser delivery systems 
[13], and most recently a tissue vaporization technique using electrical current with a 
modified rollerball called Vaportrode [14]. The more conservative options include 
watchful waiting [15], pharmacotherapy (alpha blockade, various forms of hormonal 
manipulation) [16], indwelling prostatic stents [17], and prostatic balloons [18]. These 
therapies have been shown to minimize the major complication of bleeding, TUR-
syndrome, and incontinence. In recommending a treatment option, most urologists aim 
at reducing day to day bothersome urinary symptoms and their effect on the patient's 
quality of life. Today the urologist should encourage the patient to become involved in 
making decisions about his treatment that are compatible with his attitudes and concerns 
[19]. 
The advent of new conservative, minimally invasive treatments, together with 
increased public awareness of the disease and its treatment, are likely to encourage more 
men to seek treatment for mild, moderate and sever symptoms of BPH. This will place 
increasd demands on national health care budgets. 
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Figure 1 : TheHald model shows the three fundamental aspects of clinical BPH 
Pathology and Pathophysiology. 
The role of BPH in the voiding dysfunction experienced by elderly patients is 
often unclear. The development of the disease is a slow process taking place over years. 
The three main aspects determining the clinical picture arc symptomatology, prostate 
hyperplasia (enlargement) and bladder outlet obstruction [4]. Their magnitude and the 
relative importance vary from one patient to another. The symptoms are believed to be 
the results of at least three components: the static component, the dynamic component 
and the detrusor component. The static component is the result of the formation of a 
hyperplastic nodule within the transition zone of the prostate. It is known that the 
resulting prostatic growth may produce significant pathological changes in the urinary 
tract of some patients [20]. The dynamic component involves smooth muscle tone in the 
prostate, prostatic capsule, and bladder neck. When an enlarged prostate causes 
obstruction of bladder outflow, increasing muscle tone will cause corresponding 
variations of the degree of obstruction [21]. The bladder may respond to obstruction 
with an increased incidence of uninhibited detrusor contractions and/or loss of 
contractile ability (detrusor component) [20]. It is difficult to know whether obstruction 
is the only, or the main cause, or whether other phenomena related to ageing are also 
responsible for detrusor component. Age does affect bladder function, but little has been 
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done to separate these effects from obstruction [22]. There are enormous gaps in our 
knowledge of bladder function and pathophysiology. Much of the present knowledge 
is derived from animal models. The analogy to the human situation is unproven. 
However, to make a proper diagnosis and consequently treat patients because of LUTS 
related to BPH, proper assessments is required. 
Initial evaluation 
Several agencies have provided recommendation concerning the initial 
evaluation of patients with LUTS due to BPH . The 2nd International Consultation on 
BPH patronized by WHO has recommended the workup of a standard patient 
complaining of prostatism as follows: medical history, quantification of symptoms by 
using the International Prostate Symptom Score (I-PSS ), focused physical examination 
including a Digital Rectal Examination (DRE) and focused neurological examination, 
urinalysis, and measurement of serum creatinine. Optional diagnostic tests are: 
uroflowmetry, PSA measurement, pressure/flow studies, postvoid residual urine, 
urethrocystoscopy and upper urinary tract imaging by ultrasonography. The standard 
patient is defined as: a male patient over the age of 50 years consulting a qualified 
health care provider for voiding disorders suggestive of bladder outlet obstruction who 
does not have any exclusion criteria (neurological disorders, prostate cancer, previously 
BPH treated patient, patients below age of 50, patients with diabetes mellitus or diabetic 
neuropathy and patients taking drugs affect bladder function) [23]. 
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Outline of the thesis 
The introduction of effective treatments for BPH and the growing number of 
non invasive treatments may suggest that it can be cured more easily than previously. 
These developments, in combination with changes in the social habits and increasing 
life expectancy may have some effects on the number of patients presenting with 
symptoms possibly related to BPH. Consequently the costs involved in the assessment 
increase rapidly and authorities stress to use available resources wisely. Also, as we 
move into an era where alternatives to surgery are increasingly used in the treatment of 
BPH, the time has come to consider the minimum diagnostic criteria which should be 
established before any treatment, either medical or surgical, is recommended. This study 
is a critical evaluation of the current clinical diagnostic techniques used in the 
assessment of BPH, in an attempt to define the values and to specify their position in 
a practical diagnostic way. The symptomatology of BPH is a complex issue. Though 
prostate enlargement in the elderly men is the rule rather than the exception, not all of 
those who have enlargement will experience significant symptoms. On the other hand, 
men without prostatic enlargement may experience marked symptoms suggesting 
bladder outlet obstruction [24]. Currently, urologists are studying the relation between 
symptoms and BOO. Should we mainly aim at treating symptoms, BOO or both? 
The most commonly used symptom score in patients with lower urinary tract 
symptoms (LUTS) and/or BPH is the I-PSS. Therefore in chapter 2, we studied the 
reliability of this symptom score. Also, we tried to find an answer to the question 
whether the clinician dealing with the individual patient can rely on one measurement 
of I-PSS to decide the management of the patient and to recommend therapy. 
Nowadays, the urinalysis has become accepted as an essential part of clinical 
assessment of elderly men with BPH. Because microscopic haematuria is a common 
finding in patients with BPH and this may result in a considerable number of 
investigations making the assessment in these patients unnecessarily expensive, we 
conducted a study presented in chapter 3, to evaluate the importance of the presence 
of microscopic haematuria in patients with BPH. 
A common method to estimate prostatic obstruction is the measurement of the 
prostate size using transrectal ultrasound. So how do the findings at transrectal 
ultrasound of the prostate correlate with the clinical findings? In chapter 4, we study 
the value of transrectal ultrasound evaluation of benign prostatic hyperplasia and for the 
other prostatic diseases. Another investigation frequently performed in the evaluation 
of patients with BPH is imaging of the upper urinary tract either by sonography of the 
kidney and a plain X ray of the abdomen or intravenous urography (IVU) alone. In 
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chapter 5, we correlated the results obtained during renal ultrasonography with other 
clinical parameters and provided recommendations for the indications of performing 
a renal ultrasound in patients with BPH. Also, in chapter 3, we clarified the value of 
plain X ray in patients with BPH. 
Urethrocystoscopy is still used by a considerable number of urologists in the 
diagnosis of BOO rather than urodynamic investigation. During urethrocystoscopy 
malignant diseases of the bladder, bladder stones and other abnormalities of the lower 
urinary tract can be investigated. In chapter 6, we correlate anatomical findings of 
obstruction using urethrocystoscopy with the physiological measurements of obstruction 
using urodynamic investigations with pressure-flow studies. 
Most urologists agree that only patients with BOO should be treated by 
surgical intervention and still the decision for surgical treatment is usually based on the 
nature and severity of symptoms, we studied in chapter 7, the relation between LUTS 
as measured by I-PSS and urodynamic investigation with pressure flow analysis. 
Although urodynamic investigation with pressure flow analysis is the gold standard in 
diagnosis of the BOO, other less invasive parameters are used like uroflow, prostate 
volume and postvoid residual measurements. In Chapter 8, we correlate the LUTS as 
measure by I-PSS and non invasive parameters of obstruction including uroflowmetry 
results, prostate volumes and postvoid residual urine measurements. 
Finally in chapter 9, we give an overview on the most important recommendations 
concerning evaluation of patients with BPH. 
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Chapter 2 
Reliability of the International Prostate Symptom Score (I-PSS) in the 
assessment of patients with lower urinary tract symptoms and/or 
benign prostatic hyperplasia. 
K. Ezz £1 Din, W.F.R.M. Koch, M.J.A.M. de Wildt, L.A.L.M. Kiemeney, 
F.M.J. Debruyne and J.J.M.C.H. de la Rosette 
(J. Urol, in press 1996) 
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Abstract 
Purpose: The reliability of the International Prostate Symptoms Score (I-PSS) was 
tested in patients with lower urinary tract symptoms (LUTS) and/or benign prostatic 
hyperplasia (BPH). 
Material and methods: A total of 71 consecutive men with BPH and/or LUTS was asked 
to complete the I-PSS at baseline and 8 weeks later. At the second visit the physician 
also completed the I-PSS according to the complaints of the patient. Variability between 
both scores was evaluated by the calculation of duplo errors and the results were 
compared to the clinical data. 
Results: A considerable variability existed between the I-PSS results obtained at 
baseline and 8 weeks. The duplo error was 4.3. In a regression analysis on I-PSS, 
including all clinical parameters, only free flow had some predictive value for I-PSS 
outcomes. 
Conclusion: It is important to consider the variability of the I-PSS score when making 
decisions concerning treatment. 
Reliability of the I-PSS 19 
Introduction 
Benign prostatic hyperplasia (BPH) is a common condition among elderly men 
[ 1 ]. Histologically, BPH has been reported in 50% of all men by age of 60 years, and 
nearly 100% of men older than 80 years [2]. BPH impacts significantly on quality of 
life for the aging man, primarily by producing bothersome urinary symptoms. 
Obviously, the majority of patients seek medical attention because of symptoms [3]. 
Consequently, symptoms have become the major focus in the management of bladder 
outlet obstruction (BOO) due to BPH [4]. Many urologists use symptoms as the basis 
for diagnosis of outlet obstruction and for assessing the effects of treatment. Therefore, 
a number of symptom scores have been designed to permit a more objective and 
structured history of symptoms in patients with lower urinary tract symptoms (LUTS) 
and/or BPH. 
There are several advantages in having common symptom scores such as 
assessing the efficacy of treatment of BPH, and facilitating comparison of the outcomes 
of different treatment modalities conducted at different sites and at different times [5]. 
Boyarsky et al first developed such a score [6], followed by Madsen and Iversen, and 
Fowler et al [7,8]. More recently, Hald et al developed the Danish symptom score [9]. 
In 1992 the AUA symptom score was published and it has been adopted by the World 
Health Organization as International Prostate Symptoms Score (I-PSS) [10]. The score 
has been integrated into the evaluation of patients with LUTS and/or BPH, and has been 
recommended as a precise tool for diagnosis in these patients [11]. On the other hand, 
little is known about the natural history of patients with LUTS and/or BPH, but it 
appears that the course is not necessarily one of deterioration. A considerable fraction 
of patients may show improvement or stabilization of symptoms spontaneously [12]. 
Also, the individual perception about the severity of disease may vary. Therefore, it is 
justified to question whether the clinician dealing with individual patients can rely on 
one measurement of I-PSS to recommend therapy. 
Patients and methods 
A total of 71 consecutive men with benign prostatic hyperplasia and/or lower 
urinary tract symptoms, referred to our prostate center participated in the study. Before 
therapy the patients presented twice to our department. During the first visit a medical 
history (including I-PSS) was obtained, and physical examination, free uroflowmetry 
study, post void residual measurement, biochemistry examinations (including PSA), 
urinalysis and urine culture, renal ultrasound, and transrectal ultrasonography of the 
prostate were performed. Two months (median 8 weeks) following the first visit, all 
patients underwent urodynamic investigation including pressure flow study analysis, 
and flexible urethrocystoscopy, and possible treatment options were discussed. We 
asked all patients to fill out the I-PSS at baseline and at the second visit, 8 weeks later. 
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During that visit the physician also filled out the I-PSS, according to the complaints of 
the patient 
Transrectal ultrasound was performed using the Kretz combison 330 ultrasound 
scanner with a 7 5 MHz transrectal probe (multi 3-D VRW 77 AK) The prostate was 
imaged from base to apex, documenting the presence of prostate abnormalities and 
measuring the prostate volume using the planimetrie method During the same session 
renal ultrasound was performed using the same scanner in combination with the 
abdominal probe (sector AWP 3 5 MHz) With the same probe the post void residual 
also was measured using the ellipsoid formula 
The urodynamic evaluation was performed using an 8F transurethral lumen 
catheter with an 8F intravesical microtip pressure sensor The digitally stored data were 
recorded with equipment developed at our department (UIC/BME Research center, 
Department of Urology, Nijmegen, the Netherlands) To obtain useful information from 
pressure-flow study curves, it is necessary to relate detrusor pressure to the 
correspondmg flow To quantify the grade of outlet obstruction the concept of the 
Linear-Passive Urethral Resistance Relation (hnPURR), connecting minimal urethral 
opening pressure with pressure at maximum flow, was used [13] Patients in classes 0 
and 1 of this scale do not have a urodynamic obstruction Patients in classes 2 and 3 are 
considered to have moderate bladder outlet obstruction and patients in higher classes 
have severe obstruction 
Table 1. Clinical parameters and results of total IPSS at visit 1 as completed by the patients, 
and at visit 2 as completed by patients and physicians 
Age (Years) 
Prostate volume (cm3) 
Q max (ml/sec) 
Residual volume (ml) 
hnPURR 
IPSS 1st visit 
IPSS 2nd visit 
IPSS 2nd visit Dr 
N 
71 
71 
71 
71 
71 
51 
67 
68 
Mean 
63 
43 
109 
56 
22 
169 
156 
152 
SD 
9 
22 
42 
73 
1 4 
59 
75 
64 
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Evaluation of the presence of systematic errors in the completion of I-PSS 
symptom scores was done by calculating the mean difference of the total score at the 
patient's first visit and second visit as filled out by the patient himself and his physician. 
Statistical significance of these two mean difference was tested by using the T-statistic 
as well as by calculating 95 percent confidence intervals. Random variability of I-PSS 
symptom score was evaluated by calculation of the duplo error according to: \/E(d,-
d')2/2(n-l). Where d, is the difference between the first and second measurement, d' is 
the systematic error, and η is the number of patients. In case the systematic error is 0, 
this formula reduces to: \ZE(d,2)/2n. If the interpretation of the duplo error is estimated 
to be 4 and a patient scores 20 on the I-PSS at the first visit then he might score 20± (2 
times 4)= 12 to 28 at the second visit due to random variation alone. 
The independent influence of objective parameters on the I-PSS score was 
evaluated with using multivariate linear regression models. With multiple linear 
regression analyses we also evaluated whether any of the objective parameters can 
predict a difference in the I-PSS score at the first and the second visit. In these latter 
analyses the absolute differences were modelled as dependent variable. 
Results 
The age of the patients ranged from 44 to 83 years (mean 63 years, SD ± 9). 
The mean prostate volume measured 43 cm3 (range 16-113 cm?, SD ± 22), the free 
maximum flow was 10.9 ml/s (range 1.9-22.0 ml/s, SD ± 4.2) with a mean voided 
volume of 270 ml (range 60-859 ml, SD ± 158). The post void residual appeared to 
range from 0-280 ml (mean 56 ml, SD ± 73), and the mean linPURR value was 2.2 
(range 0-5, SD ± 1,4). In table 1 the results of the I-PSS at the first visit as filled out by 
the patients (PI), at the second visit as filled out by the patients (P2) and at the second 
visit as filled out by the doctor (D) are presented. There appeared to be no statistically 
significant systematic difference between I-PSS scoring at first and second visits. The 
I-PSS at PI minus P2 results in a mean difference (=systematic error) of 1.6 points. The 
standard error of this mean is 0.9, resulting in a 95% confidence interval of -0.1 to 3.2. 
Zero lies in this interval, and therefore there is no statistically significant systematic 
error (p=0.07). However, when looking at the result of the I-PSS at PI minus the I-PSS 
at P2, some considerable differences can be noticed (see figure 1). Both patients with 
higher and lower scores at the second visit can be observed. There seems to be a 
tendency in these patients to be skewed to the right side in this figure meaning a 
somewhat lower I-PSS score at the second visit. When looking at the individual 
questions, number 1 and 4 seem to have the highest random variation and question 7 
seems to have the lowest (figure 2). The duplo error between the first and second visit 
was 4.3. 
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Concerning P2 minus D, the systematic error was 0.5 with a 95% confidence 
interval of-0.6 to 1.6, which was not significant. Again, a significant number of patients 
had a different score at the second visit as noted by the patients and physicians, with the 
patient scores somewhat higher than the score of the doctor (see figure 3). Question 4 
had the highest and question 7 had the lowest random variation. 
When comparing the outcome of the I-PSS at the first visit (PI) and the second 
visit (P2), the correlation appeared to be 63% (Pearson test). The correlation between 
the I-PSS score of P2 and D is 77% (Pearson test). The duplo error between the total 
I-PSS score as filled out by the patient and by the doctor at the second visit was 
calculated to be 3.4. In a linear regression analysis on I-PSS related to patient age, 
maximum free flow, post void residual, prostate volume and linPURR, only the free 
flow has some predictive value for I-PSS (table 2). There is a statistically significant 
inverse correlation between the standard I-PSS and the free flow. If one scored 1 point 
higher on the free maximum flow scale, he scored 0.82 point lower on I-PSS. Moreover, 
none of the objective parameters predicted a difference in the I-PSS score at either visit. 
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Fig. 2. Histogram for difference between patient (P) IPSS scores at visits 1 and 2 regarding 
questions (Q) 1 to 7 of IPSS score and quality of life QL question. 
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Table 2. Linear regression analysis on IPSS of different clinical and urodynamw parameters 
Linear regression analysis on IPSS 
Intercept 
Age (year) 
Q max (ml/sec) 
Residual volume (ml) 
Prostate volume (cm3) 
hnPURR 
'
J
 coefficient 
2104 
0 04 
-0 82 
-0 01 
0 04 
-1 04 
SE 
8 04 
0 12 
0 24 
001 
0 05 
2 69 
p 
x
 value 
001 
0 73 
0 001 
0 44 
0 35 
0 70 
Discussion 
The most widely used symptom score in the assessment and follow up of 
patients with LUTS and BPH is the I-PSS (table 3) To rely on this questionnaire, it is 
mandatory to evaluate the test reliability Barry et al noted that test reliability can be 
increased by basmg decisions on the mean of 2 or more measurements from the same 
patient [14] Because symptoms can wax and wane, data to estimate within-patient 
variability must come from repeated measures of the variable during a period short 
enough so that it is unlikely that true consistent changes in patient condition have 
occurred In our study the majority of measurements were repeated within 8 weeks This 
interval was chosen because the waiting list for the second visit takes that long We 
observed a tendency for lower scores at the second visit, 8 weeks later This is difficult 
to explain Maybe the learning effect results in a lower score the second time or the 
patient better observes his voiding and documents it more accurate Another explanation 
is that the patient experiences his complaints as being more serious than they actually 
may be They may initially be worried to have prostate cancer and are less concerned 
when this is ruled out Indeed, the patients tend to overestimate their complaints, which 
is illustrated by the higher score filled out by the patient than the one filled out by the 
doctor (table 1) In general, however, our results are within the 95% confidence 
intervals Therefore we concluded that no statistically significant systematic error exists 
Although we do not expect a systematic error we do expect a significant random 
variation In the present study, the duplo error for the difference between PI and P2 for 
the total I-PSS score was 4 3 A similar conclusion can be made when measuring the 
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Fí£. 3. Histogram for difference between patient(P) and physician (D) IPSS scores at visit 2 
duplo итог of the I-PSS at the second visit by the patient (P2) and the doctor (D). This 
error was somewhat smaller than the duplo error of the first and second visit by the 
patient. 
The changes found in the total I-PSS score between Ρ1 and P2 and between P2 
and D are presented in figures 4 and 5. If a score of more than 12 is mandatory for 
inclusion in a treatment protocol, 24% (n=12) of patients did and did not comply with 
this requirement at the first and second visit respectively. This is a considerable number 
of patients and therefore we believe that the decision on whether to treat or not to treat, 
using symptom scores as the "sole" criterion, should be made at an interval of 8 weeks. 
Also, we learned from a study in a large number of patients followed according to a 
watchful wailing protocol that those patients without urodynamically proved obstruction 
had fewer complaints at 6 months follow up, while those with obstruction still had a 
symptom score at the same level [12]. Therefore, we should perhaps include the results 
of urodynamic studies with pressure-flow study analysis to improve the reliability of 
the I-PSS results. However, in a considerable number of studies no significant 
correlation between the results of symptom scores and urodynamic studies were found 
[15]. Also in the current study, a regression analysis showed that the grade of bladder 
outlet obstruction (expressed by the linPURR result) had no predictive value for the I-
PSS. 
The diagnosis of patients with BPH and/or LUTS and the decision to treat, are 
based largely on the nature and severity of the presenting symptoms [3]. During recent 
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years we learned that the presenting complaints are not caused by a single factor but by 
a combination of factors. The recommendation that objective evaluations arc optional 
may tempt clinicians to refrain from their use and, thus, only rely on symptoms. In view 
of the emerging newer and more complex technologies that we are regularly absorbing 
in our armamentarium [16-19], all efforts must be made to obtain accurate tools for 
assessment and evaluation in patients presenting with complaints. From the current 
study we learned that, at an interval of 8 weeks, one quarter of all patients no longer 
complied with the inclusion criteria for treatment used at our department which is in 
accordance with previous findings f 14]. We agree that the I-PSS symptom score can be 
an important tool in assessing patient perception of the clinical problem, and should be 
used only for baseline and follow up evaluation of these patients. Moreover, we think 
that it is important to keep in mind the variability of the I-PSS score when making 
decisions concerning (surgical) treatment. Therefore, we recommend that at the baseline 
preferably two I-PSS scores should be taken and the second score to be used as baseline. 
In case of significant difference in scores, may be, a third I-PSS score should be taken 
at 8-wceks interval before deciding to treat or not to treat. If a similar recommendation 
for the I-PSS score should be given at the follow up cannot be answered from the 
current study. 
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Table 3. IPSS score 
INTERNATIONAL PROSTATE SYMPTOM SCORE (I-PSS) 
Not al all less than 
1 time in 
5 
less than 
half the 
time 
About half 
the time 
More 
than 
halfthe 
time 
Almost 
always 
1 Over the past month, how often have 
you has a sensation of not emptying 
your bladder completely after you 
finished urinating 
2 Over the past month, how often have 
you had to urinate again less than two 
hours after you finished urinating 
3 Over the past month, how often have 
you found you stopped and started again 
several times when you urinated7 
4 Over the past month, how often have 
you found it difficult to postpone 
urination? 
5 Over the past month, how often have 
you had a weak urinary system7 
6 Over the past month, how often have 
you had to push or stram to begin 
urinali on? 
None 1 time 2 times 3 limes 4 times 5 or more 
times 
7 Over the past month, how many 
times did you most typically get up to 
urinate from the lime you went to bed 
at night until the time you got up in the 
morning7 
TOTAL I-PSS Score S = 
QUALITY OF LIFE DUE TO URINARY SYMPTOMS 
Delighted Pleased Mostly 
satisfied 
Mixed about 
equality 
satisfied and 
dissatisfied 
Mostly 
Dissali 
sfied 
Unhappy Temblé 
1 If you were to spend the rest of your 
life with your unnary condition just the 
way it is now, how would you feel 
about that7 
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Fig. 4. A, Scatterplot of patients IPSS scores at visit 1 and 2 for 49 patients. Correlation 
coefficient is 0.63. B, scatterplot of patient and physician IPSS scores at visit 2 for 66 patients. 
Correlation coefficient is 0.77. 
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Abstract 
Objectives To determine the additional value of the presence of microscopic 
haematuna in patients with benign prostatic hyperplasia (BPH) 
Methods In 750 consecutive patients with BPH urinalysis was performed and the grade 
of microhaematuna was correlated with other cluneal findings 
Results Microscopic haematuna was found m one third of the patients Only 3 had a 
bladder tumour and 49 patients had urinary calculi for which only one patient required 
treatment There was no correlation between any clinical parameter and the finding of 
microscopic haematuna 
Conclusion Microscopic haematuna is a frequent findmg in assessment of BPH 
patients and additional tests should only be performed if indicated 
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Introduction 
Male bladder outlet obstruction has presented a clinical problem throughout 
medical history. As early as in the 17th century it was suggested that benign prostatic 
hyperplasia (BPH) could result in mechanical obstruction to the bladder outlet tract [ 11. 
Nowadays, BPH is the most common pathological condition to afflict the aging male 
and an almost universal finding in elderly men with bladder outlet obstruction. This 
obstruction may eventually result in voiding complaints, inefficient bladder emptying 
with a poor urinary flow and post-micturition residuals. It is at this juncture that the 
patient usually seeks medical advice either because of troublesome symptoms or 
complaints secondary to the worsened voiding. 
Each patient, who on clinical grounds is suspected as suffering from lower urinary tract 
symptoms (LUTS) secondary to BPH should undergo screening investigations to assess 
renal function, urinary infection and the possibility of the associated urinary tract 
dysfunction either mimicking or coexisting with the suspected abnormality. These 
investigations should include urinalysis, which is considered a standard to perform in 
the evaluation of elderly men with LUTS, and the results of urinalysis should include 
the presence of leucocytes or erythrocytes [2]. 
Although urinalysis has become accepted as an essential part of clinical 
assessment, there is evidence that urinalysis is not a good screening procedure because 
of the low predictive value. Though abnormalities are found in approximately a third 
of the tests, the therapeutic yield is very small, leading to change of treatment in only 
1-2% of the patients [3-4]. On the other hand, erythrocyturia is an alarming finding, and 
it is reported that 4.8-16.5% of adults with asymptomatic microerythrocyturia have 
serious urologie diseases [5-7J. Until now, however, no paper has been published on 
the finding of erythrocyturia in relation to patients with LUTS and BPH. In view of the 
high incidence of patients with micturition complaints that may be related to the 
prostate gland, further evaluation is mandatory. The finding of erythrocyturia may result 
in a considerable number of (unrewarding) investigations making assessment in these 
patients unnecessarily expensive. Therefore, we conducted this study, evaluating a large 
number of patients with prostate related voiding complaints to determine the additional 
value of the finding of erythrocyturia in these patients. Finally, we would like to provide 
recommendations for additional examination in patients with microscopic 
eryrhrocyturia. 
Patients and Methods 
The rationale and methods for this study were, 750 consecutive men seen at our 
outpatients' department with benign prostatic enlargement and lower urinary tract 
symptoms, either irritative or obstructive [8], subjected to urinalysis by dipstick 
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readings (Combi 9 test-Bœhringer) and, if positive, urine sediment microscopy was 
done. Moreover, all patients underwent a screening program including history 
(including the IPSS symptom score), physical examination (including digital rectal 
examination), biochemistry (including PSA and serum creatinine), urine culture and 
cytology, transrectal ultrasonography, a plain abdominal X-ray, a renal ultrasound, and 
a flexible cystoscopy. Objective voiding parameters were evaluated by a free urinary 
flow, post void residue, and urodynamic investigations with pressure flow analysis. 
During the first consultation, urine was obtained from a clean mid-stream 
specimen. If urinalysis by dipstick revealed erythrocytes, microscopy was performed. 
Sedimentation grading was done by standard methods under high-power-field (HPF) 
magnification. The presence of no red blood cells (RBC) was considered grade I, 1-5 
RBC grade II, 6-10 RBC grade III, and more than 10 RBC grade IV. Besides for 
haematuria, also the presence of leucocytes, abnormal cells and/or bacteria were 
evaluated. 
Before further examinations, blood was taken for biochemistry including PSA. 
Transrectal ultrasound was performed using the Kretz combison 330 ultrasound scanner 
with a 7.5-MHz transrectal probe (multi 3-D VRW 77 AK). The prostate was imaged 
from base to apex, documenting the presence of prostate abnormalities and measuring 
the prostate volume using the planimetrie method. In the same session, a renal 
ultrasound of the kidneys was performed using the same scanner in combination with 
the abdominal probe (sector AWP 3.5 MHz). In case of any abnormalities such as 
dilatation or calculi, an additional ultrasound investigation was performed by the 
Department of Radiology. With the same probe, also the post void residue was 
measured, using the ellipsoid formula. Screening of the upper urinary tract is finalized 
by performing a plain abdominal X-ray searching for urolithiasis or skeletal 
abnormalities. 
During the second visit, a flexible cystoscopy was performed (Storz flexible 
cystoscope) to evaluate the patency of the urethra, the prostate size, and bladder 
abnormalities such as bladder stones or the presence of papillary lesions. Finally a 
urodynamic evaluation was performed with an 8F transurethral lumen catheter with an 
intravesical microtip pressure sensor (MTC, Drager, Germany). The digitally stored 
data were recorded with equipment developed at our department (UIC/BME Research 
Center, Department of Urology, Nijmegen, the Netherlands). In order to get useful 
information from pressure flow-curves, relating detrusor pressure to the corresponding 
flow is necessary. To quantify (changes of) the grade of obstruction, the concept of the 
linear passive urethral resistance relation (linPURR), connecting minimal opening 
pressure with pressure at maximum flow, was used [9]. Grade 0-2 is regarded as 
minimally obstructed, grade 3-4 as moderately obstructed, and grade 5-6 as severely 
obstructed. 
For statistical analysis, the Spearman rank correlation was used. 
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Results 
The study included 750 males with an average age of 64 years (range 40-85), 
and prostate size ranging from 12 to 160 cm3 (average 44 5 cm3) All of our patients 
with positive dipstick readings were found to have red cells on microscopy A total of 
516 patients (68 8%) had no haematuna, 207 patients (27 2%) had 1-5 RBC, 15 
patients (2%) had 6-10 RBC, and 12 patients (1 6%) had more than 10 RBC There 
appeared to be no relationship between the presence or the grade of erythrocytuna and 
the age of the patients (Spearman correlation=0 10) The results of symptom score 
(IPSS symptom score) related to sedimentation grading is presented in table 1 There 
also appeared to be no correlation between prostate volume or post void residue and 
haematuna (table 2 & 3) Unne culture revealed a urinary tract infection in 17 patients 
without a correlation with the grade of haematuna (table 4) 
Table 1. Erythrocytuna in combination with IPSS score 
I II III IV total 
IPSS 8(1-15) 7 7(1-15) 7 6(1-14) 5 8(1-10) 7 9(1-15) NS 
ìmt* 
IPSS 9 7(1-20) 10(1-20) 10 1(2-20) 8 4(2-15) 9 4(1-20) NS 
obst* 
total 17 6(1-35) 17 7(1-34) 17 7(1-31) 14 2(1-24) 17 5(1-35) NS 
IPSS 
NS=correlation is not significant 
imi ^irritative complaints 
obst =obstructive complaints 
The plain abdominal X-ray showed unnary calculi in 49 patients in 71 4% of 
cases no haematuna was found, in 24 5% grade II haematuna, and grade III and grade 
IV was found in 2% of the patients each Most of the calculi were small (< 2 mm) and 
all of the patients experienced no complaints related to these stones Only 1 patient 
eventually required extracorporeal shock wave lithotnpsy treatment because of the 
impact of the stone load found At renal ultrasound scanning we found one renal 
tumour, dilatation in 14 cases, and renal cysts in 61 patients All cases of dilatation were 
due to outlet obstruction There was no correlation between the presence of dilatation 
or the presence of renal cysts and haematuna 
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Urethrocystoscopy showed the presence of a papillary lesion in 3 patients (table 
5) One of these patients had no haematuna and 2 patients had only 1 -5 erythrocytes per 
HPF in the sediment Obviously there was no correlation between the presence of a 
urothelial cell carcinoma and the grade of haematuna The results of the histology are 
described in table 4 Unne cytology showed sever atypia in only 1 patient and negative 
cytology in the other 2 patients 
Table 2. Correlation between erythrocytes grade (I-IV) and prostate volume 
prost vol 
<20cm3 
20-40 cm3 
40-60 cm3 
60-80 cm3 
> 80 cm3 
I 
11 (68 7%) 
263 (71 8%) 
126(68 9%) 
47 (58 0%) 
33 (57 8%) 
II 
4 (25 0%) 
95 (26 0%) 
49 (26 8%) 
31(38 3%) 
18(316%) 
III 
1 (6 3%) 
4(1 1%) 
5 (2 7%) 
1 (1 2%) 
3 (5 3%) 
IV 
0 (0 0%) 
4 (1 1%) 
3(16%) 
2 (2 5%) 
3 (5 3%) 
total 
16 
366 
183 
81 
57 
prost vol=prostate volume 
Finally analysis of the bladder outlet obstruction (BOO) showed that almost 
50% of cases had only minimal grade of obstruction, more than 30% had moderate 
obstruction and the remaining patients had severe BOO Spearman analysis showed no 
correlation between BOO and haematuna (r = 0 03) (table 6) As for the relation of 
haematuna and post voiding residues, we found that 447 men had residuals less than 
50 ml, 115 patients had a residual of 50-100 ml, 128 patients a residual of 100-250 ml 
and 45 patients had a residual of more than 250 ml The correlation between the 
erythrocytuna and the post voiding residual was statistically insignificant (table 3) 
Table 3. Correlation between erythrocytes grade (I-IV) and the residual urine 
residue 
<50 ml3 
50-100 ml3 
100-250 ml3 
>250 ml3 
I 
300 (67 1%) 
83 (72 2%) 
96 (75 0%) 
27 (60 0%) 
II 
134(30 0%) 
26 (22 6%) 
31 (24 2%) 
12(26 6%) 
III 
8 (1 8%) 
3 (2 6%) 
1 (0 8%) 
3 (6 7%) 
IV 
5 (1 1%) 
3 (2 6%) 
0 (0 0%) 
3 (6 7%) 
Total 
447 
115 
128 
45 
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Table 4. Correlation between the sediment grades and urological diseases . 
Grade 
noofpts 
stones 
tumours 
dilatation 
cyst 
cult. +ve 
I 
516 
35 
1 
10 
39 
7 
II 
207 
12 
2 
3 
11 
9 
III 
15 
1 
0 
0 
10 
0 
IV 
12 
1 
0 
1 
1 
1 
Total no 
750 
49 
3 
14 
61 
17 
no ofpts= number of patients, 
cult, t ve = culture positive 
Discussion 
Benign prostatic hyperplasia is a common disease in elderly men. Its impact on 
medical care is increasing due to the ageing of the population and changes in social 
habits, and it is estimated that eventually one third of all males will require therapy for 
relief of voiding complaints due to BPH. Moreover the treatment of BPH is currently 
undergoing significant re-evaluation and several minimal invasive alternatives to 
surgery have emerged during the past few years. 
As it is true for any disease process, the assessment of a patient presenting with 
voiding complaints and BPH should be directed toward identifying those patients who 
have BPH, and to exclude other underlying disease processes. Thus, our efforts have to 
focus mainly on identifying those patients who do not suffer from BPH, but from other 
conditions causing similar symptoms, and to exclude a serious disease such as a bladder 
carcinoma. 
The clinical evaluation of patients suffering from BPH relies upon the 
interpretation of clinical symptoms aided by the appropriate application of objective 
tests. One of the most frequently performed tests in urology is a urinalysis, and the 
WHO recommends the urinalysis as a standard to perform in the assessment of BPH. 
Besides the presence of leucocytes during microscopy, especially the presence of 
haematuria is of major importance. However, most physicians are often unsure how 
aggressively to pursue urologie evaluation of a patient with asymptomatic 
microhaematuria. On one the hand, it is suggested that this test is relatively inexpensive 
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and that in older men with BPH the benefits of such a test as this clearly outweigh the 
harm involved. Several studies have found that a considerable number of men will 
eventually develop cancer or other urological diseases. The commonest abnormalities 
of hacmaturia in the BPH age group are bladder carcinoma, renal cell carcinoma, urinary 
calculi and acute urinary tract infection. Glomerular causes are indicated if RBC casts 
arc found in the urinary sediment or if RBC are of abnormal morphology. In the present 
study, no special tests were conducted to exclude glomerular causes. 
In a population based study by Mohr et al. [7] asymptomatic microhaematuria 
was a common finding, occurring in 13% of the population. In another study by 
Messing et al. [10], it was shown that the positive predictive value of this finding was 
26%, possibly due to the use of sophisticated follow up studies. On the other hand, 
Sandler et al [11] found that routine urinalysis contributed little useful information and 
deplored the consequent waste of money. 
First the grade of haematuria is considered important in the evaluation. Mohr 
et al. [12] comment that in determining the necessity of initiating a diagnostic work up 
in patients with asymptomatic microscopic haematuria, one often considered the grade 
of haematuria. However, previous studies as well as the present study have not found 
this to be related to disease severity [5-7-10]. Also, age has been used to determine 
which patients should be evaluated further. Greene et al. [13] found that non of their 
serious urologie lesions occur in patients younger than 50 years. On the other hand, 
Mohr et al. [12] found that especially in the older patients, urothelial cancer occurred 
The latter was confirmed in the present study where we saw 3 (0.4%) cases of bladder 
urothelial tumours in patients above 50 years old. 
Table 5. Findings at urethrocystoscopy, cytology and histology in patients with bladder 
carcinoma. 
cystoscopy sedimen gr cytology Histology 
patients stage grade 
1 single papillary I negative PTa lib 
2 single papillary II negative PTa Па 
3 multi, papillary II sever atypia PTa ПЬ 
Sedimen gr. =Sedimentation grade 
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In the current study there appeared to be no correlation between the grade of 
haematuna and the finding of urothelial cancer There appeared to be no patients with 
a prostate carcinoma in this group because these patients were excluded from further 
assessment for BPH once a prostate carcinoma was suspected One renal cell carcinoma 
was detected and this is in accordance with the incidence m the general population [14] 
Another cause for microhaematuna may be the presence of nephrolithiasis 
This presents a significant burden to society and the health care system It is estimated 
that the prevalence in adults is 2-3%, and that 10% of the population will have renal 
calculi during their lifetime [15] Of the symptomatic calculi 70% pass spontaneously, 
while 30% require intervention [16] The 5-year recurrence rate is 20-50% [17] We 
found that although 49 patients showed nephrolithiasis on the plain abdominal X-ray, 
only 1 patient required treatment Therefore, we think that one should consider to 
perform such a study only m the case of disease-related complamts Upper tract 
dilatation is the most common findmg m patients with bladder outlet obstruction with 
the reported incidence ranging from 3 to 13% [18-19] In our senes, hydronephrosis 
was found in 1 9% of patients and has no correlation with erythrocyte grading The 
prevalence of simple renal cysts (8 1%) is expected for patients in this age group [20-
21] 
Finally, no studies been conducted correlating BOO, prostate size or post void 
residues with microhaematuna From the present study, we have learned that no 
correlation could be found 
Table 6. Correlation between erythrocytes and outlet obstruction according to linPURR 
lm-PURR I II III IV total 
0-2 258(70 1%) 104(28 3%) 4(11%) 2(0 5%) 368 
3-4 155(64 0%) 72(29 8%) 9(3 7%) 6(2 5%) 242 
5-6 54 (73 0%) 16 (216%) 1 (14%) 3 (4 1%) 74 
lmPURR=hnear Passive Urethral Resistance Relation 
In conclusion, minor grades of microhaematuna are frequently diagnosed in 
patients with voidmg complaints and BPH There seems to be no correlation between 
the grade of haematuna, age, prostate size, symptoms, post void residues, the grade of 
bladder outlet obstruction, the presence of nephrolithiasis or bladdertumours 
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Malignancy is the most important diagnostic consideration and appeared to be 
0.4% in the present study and nephrolithiasis was diagnosed in 6.5% of the patients of 
whom only 1 patient required treatment. The specific problem will be to diagnose any 
of these serious conditions while minimizing the costs and morbidity associated with 
diagnostic evaluations. We therefore consider the 3 cases of bladder tumour as an 
incidental finding, consequently a urethrocystoscopy should not be included in the 
assessment of patients with BPH and only be performed on indication. We would like 
to emphasize that all patients in the present study primarily consulted our department 
because of BPH and related voiding symptoms. This may explain the relatively low 
incidence of bladder tumours in the current study. On the other hand, patients obviously 
primarily seen because of (microscopic) haematuria should consequently undergo 
further evaluation with screening of upper urinary tract and urethrocystoscopy. Finally, 
also, a plain abdominal X-ray is not to be recommended in patients with BPH and 
voiding complaints because the outcome docs not change the treatment policy and 
should only be performed in the presence of upper urinary tract complaints. 
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Introduction 
Ultrasound is a branch of acoustics that deals with the study of sound waves 
of frequencies above those within hearing range of the average person [1]. During 
World War II, the principles of ultrasound were used to develop SONAR (SOund 
Navigation And Ranging ). It was mainly as a result of this application, that special 
attention was paid to further development of this technology. Ultrasound in urology was 
first applied to the kidneys and bladder in the 1950s but there was no general 
acceptance then because of poor image quality [2]. During the last 25 years, however, 
a rapid development in ultrasound could be achieved by the introduction of gray-scale 
and real-time scanning. Moreover intracavital scanning such as transrectal 
ultrasonography (TRUS) substantially increased the potential value of ultrasound in 
urology. 
TRUS of the prostate is a rapidly advancing modality with growing acceptance 
and importance for diagnosis and management of prostatic diseases. Since its clinical 
application in 1971 by Watanabe, transrectal ultrasound has now developed into a 
sophisticated technology [3]. Early in the history of transrectal ultrasonography, 
bistable 3 MHz transverse images provided only information about prostate size and 
shape [4]. In the late 1970s and early 1980s, gray scale longitudinal and transverse 
scanners were introduced [5]. It was not until then that visualization of the internal 
architecture of the prostate became possible, and two zones were identified: the 
transition zone and the external zone. In 1985, studies were done with 5.0 MHz 
scanning in both transverse and longitudinal planes. Recent advancements of electronic 
real time ultrasound have improved dynamic ultrasound imaging significantly. Finally 
in 1986,7.0 MHz scanning was introduced and the improvement in resolution allowed 
visualization of the infrastructure of the prostate, corresponding to McNeal's concept 
of zonal anatomy [6]. 
Sonographic appearance of the prostate 
There is no accepted standard for topographic relationships in prostate imaging. 
The prostate is best considered as a fusion of different glandular regions contained 
within a discontinuous capsule [7]. McNeal first proposed the concept of different zones 
of the prostate gland: the transition zone, the peripheral zone, and the central zone [8]. 
In young men the normal inner prostate is generally low level in echogenicity as 
compared with the outer gland. As the transition zone enlarges, a distinct demarcation 
between these two regions can readily be appreciated. The transition zone images as 
hypoechoic as compared with the generally isocchoic peripheral zone. With increasing 
enlargement the transition zone can compress the central zone and the peripheral zone. 
The margin separating the hyperplasia from the peripheral zone is considered to be the 
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surgical capsule. The hyperplasia can further allow visualization of multiple adenomas, 
or even capsular bulging, but never capsular infiltration [9]. Besides benign prostatic 
enlargement, other prostatic diseases can also be visualized. The use of TRUS in the 
detection of prostatic cancer was first described by King et al [4] among others. In early 
prostatic ultrasonography, using low-frequency probes, it was suggested that prostate 
cancer was densely echogenic or hyperechoic [4,10]. Through the 1980s higher 
frequency probes, combined with gray-scale imaging, markedly improved the imaging 
of the prostate and intraprostatic anatomy could, reproducibly, be defined. It is now 
generally accepted that prostatic cancer can have certain echographic variability, and is 
influenced by tumor grade, stage, size and location. Shinohara and colleagues compared 
the ultrasound appearance with histologic findings and determined that approximately 
60% to 75% of prostate cancer appear hypocchoic (fig 1), whereas 25 % to 40% are 
isoechoic, and 1% to 2% are hyperechoic [11]. Other criteria that help in the 
differentiation of prostate cancer include asymmetry in size particularly in the peripheral 
zone, capsular distortion and loss of normal demarcation between the central gland and 
the peripheral zone [9,12,13](fig 2). The exact reason for these differences in the 
echogenic appearance of prostatic cancer is uncertain but may be related to the index 
of cellular differentiation, tumor size, intermixing of BPH with cancer, fibrotic changes, 
and other as yet undefined causes [14,15]. 
Finally, the transrectal ultrasonographic appearance in patients with 
inflammatory prostatic diseases is still under discussion. Echogenic and hypoechoic 
findings throughout the gland have been reported [16,17]. The only image that is agreed 
upon to be characteristic in inflammation of the prostate is the presence of an anechoic 
to a hyperechoic lesion with a thin or a thick wall. To reach the proper diagnosis the 
sonographic findings should be complementary to the clinical findings. 
Considerations concerning TRUS. 
Several aspects need to be considered when performing TRUS. First, before 
ultrasonography, the operator should be aware of the history of the patient and the 
findings at digital rectal examination (DRE). Therefore it is recommended that the 
examiner should always do a DRE and include these findings in the interpretation of the 
ultrasound image of the prostate. Moreover, ultrasonography of the prostate is a 
dynamic process. Subtle abnormalities noticed during a TRUS are often poorly 
presented on a photographic print. Therefore, the interpreter of ultrasonographic 
findings and the operator of the machine should be the same person. The technique used 
to perform the investigation is also important. Transrectal ultrasound evaluation is 
optimally performed using axial, sagittal and oblique coronal-axial projections, 
manipulating the probe within the rectum to ensure that all areas of the gland lie within 
the optimal focal zone of the transducer. The use of at least two imaging planes allows 
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visualization m three dimensions, thus permitting more accurate localization of 
abnormalities and extent of disease The initial scan is made with some stand off from 
the postenor prostate Placing the prostate within the near field is better without overly 
compressing the peripheral zone An additional scanning pass should be made with the 
probe slightly compressing the prostate, which improves ultrasound penetration and 
evaluation of the anterior prostate while possibly enhancing any subtle posterior 
abnormalities Compression in the sagittal plane may also be required for height and 
width measurements in large glands In the sagittal projection, levering the probe 
quickly from the far left to the far right aspects of the gland may help confirm any subtle 
hypoechoic asymmetry or architectural distortion in the lateral peripheral zones as seen 
on axial scanning 
Applications of TRUS 
The applications of TRUS will be discussed under the following headings (1) Prostate 
volume, (2) prostate biopsy, (3) prostate cancer, (4)TRUS aided therapies and (6) 
future developments 
Prostate volume 
Estimation of prostate volume may be useful in a variety of ways A precise 
estimate of the amount of benign prostatic hyperplasia would help to decide the 
appropriate therapy and assist m the interpretation of serum prostate specific antigen 
level for the presence of cancer [18] Also, the decrease in the prostate mass after 
hormonal manipulation or radiation therapy can be used as an indication of therapeutic 
efficacy [19] As the goal of many researchers has been an accurate estimation of 
prostate volume so, there have been several studies performed to this end [ 18-22] 
Earlier studies applied suprapubic ultrasound to measure prostate size Although some 
studies reported accurate results with this technique, others felt this method had an 
inherent problem [20] An accurate estimation of the prostate volume only seems 
possible, however, when doing the investigation transrectally The three most 
commonly used methods for estimation of the size of the prostate are the planimetrie 
method, the method using the three dimensions of the prostate, and the ellipsoid method 
The step section planimetrie method mcludes a sequential area summation of multiple 
sections of the prostate [21] The method usmg the three dimensions of the prostate 
includes measurements of height (H), width (W), and length (L), and the formula used 
to calculate the volume is HWL χ π/6 [22] The ellipsoid volume calculation is a feature 
available on some ultrasound scanners that allows the operator to delineate the prostate 
contour at transverse midgland level and then define a hypothetical axis of rotation for 
that area with distance markers The formula used to generate the volume calculation 
is =8A/3TIL, where A is the area of the outlmed ellipse and L the length determined by 
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distance markers. It is generally accepted that the step section planimetry method of 
volume determination is most accurate [23,24] but it is tedious and time consuming. 
In addition, this method requires sophisticated software to execute the program. 
Therefore the best formula to estimate prostate volume is a variation of the prolate 
spheroid formula using the transverse diameter as the major axis and the anteroposterior 
diameter as the minor axis. This formula is optimal for prostates weighing less than 80 
gm. In large glands, more than 80 gm., the spherical volume formula using the 
transverse diameter 7t/6(transverse diameter)3, provides the best estimation of prostate 
weight [22]. The use of this formula in preference to those using the length of the 
prostate is supported by the difficulty of measuring the latter accurately. The 
measurement of ccphalocaudal distance is sometimes technically difficult, since the 
point of juncture between the prostatic apex and distal urethra is frequently poorly 
visualized. Likewise, the definition between the base of the prostate and the seminal 
vesicles and the bladder neck is not often well seen [22,23]. Finally the ellipsoid 
volume techniques are rapid and available on most ultrasound machines, yet are not as 
accurate as the previous two methods [25]. 
To overcome inaccuracy in the volume measurements, an automated method 
for volume determination has been investigated at our department [26]. This method is 
based on planimetrie volumetry to overcome subjectivity in prostate volume 
measurements using ultrasonography (fig 3). Moreover, this method is a useful tool in 
the objective determination of the prostate specific antigen in proportion to the volume 
[27]. 
Prostate biopsy 
The presence of prostate cancer can be established only through histologic 
tissue sampling. The main purpose of transrectal ultrasound guided biopsies is to 
obtain tissue for histologic diagnosis. To identify areas of potential extraprostatic 
spread and to achieve an accurate histologic grade, several cores should be obtained by 
using strategic transrectal ultrasound guided biopsies of known sites of anatomic 
weakness [28]. Sonographically guided prostate biopsies initially used a transperineal 
biopsy approach with transrectal scénographie guidance [29]. Although initially 
described, using an axially oriented scanner greater accuracy and simplicity were 
obtained by using the longitudinally oriented sonogram for guidance. The availability 
of an automatic biopsy device that uses an 18 gauge biopty needle has facilitated 
biopsies via the transrectal route. This route has many advantages. It is relatively 
painless, easily performed, readily accepted by the patients and it is highly accurate for 
small lesions [30]. Biopsy complications can include haematuria, bleeding per rectum, 
clot retention, septicemia or urinary tract infection. To reduce the potential biopsy 
complications, the patients should be asked if they have had any bleeding dyscrasia, use 
warfarin sodium, have a prosthetic heart valve or joints, and if they have clinically heart 
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murmurs, any of which may indicate that appropriate prophylaxis should be used [31]. 
Which strategy is best to perform prostate biopsies under transrectal ultrasound 
guidance? Several approaches have been proposed. It is either random systematic versus 
directed ultrasound guided biopsies. If the lesion is visible, obviously this should be 
biopsied. If no lesion can be detected and suspicion is present for prostate cancer 
random biopsies should be considered. Hodge and colleagues stated that random 
systematic biopsies guided by ultrasound provide valuable additional information on 
cancer volume if present [32]. Others have supported the utility of this biopsy technique 
for detection of prostate cancer [33]. Additionally, the extent of a tumor in each biopsy 
core has been used as an indicator for tumor volume [32]. The disadvantages include 
the possibility of detecting insignificant small tumors and not knowing how largely a 
cancer can be missed by this technique [34]. Random systematic ultrasound guided 
transrectal biopsies are ideal in detection the 68% of cancer arising in the peripheral 
zone and 8% arising in the central zone, but cannot help with the 24% that arise in the 
transition zone [32]. Terris and associates advocated measuring the extent of cancer in 
patients with only one positive biopsy [35]. The volume of cancer was proportional to 
the length of cancer in the biopsy core, and additional biopsies were done on patients 
with a tumor of 3 mm or smaller on one positive biopsy. In view of this elegant 
technique, cytologic aspiration biopsies are only of limited use and not to be 
recommended. 
Prostate cancer. 
Accurate staging is an important guide to prognosis and forms the basis upon 
which initial management of patients with prostatic cancer is decided [36]. Digital rectal 
examination often underestimates the extent of the disease [37], sometimes 
overestimates [38], and correlates poorly with the actual volume of cancer [39]. 
Transrectal ultrasonography is the most used imaging technique for diagnosis and 
staging of prostatic cancer and it offers some valuable complements to the DRE and 
prostate specific antigen (PSA) results [42]. McNeal with his description of the zonal 
anatomy of the prostate has identified the likely sites of cancer within the gland and 
provided further understanding of the way in which prostate tumor spreads [7]. Lee and 
his colleagues have described two potential weaknesses for possible extraprostatic 
spread [28]. The invaginated extraprostatic space follows the ejaculatory duct and 
extends to the vcrumontanum. The seminal vesicle's beak is the site of entrance of the 
seminal vesicles and vas deferens into the central zone. In both cases, no capsules 
surround these areas [8]. On transrectal ultrasound one should also consider the 
possibility of capsular penetration when any bulging, thickening, irregularity or 
asymmetry is present. Although TRUS is operator dependant, it has the capacity to 
characterize the tumor by volume, location and extent, and therefore provides valuable 
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clinical staging [41]. Scardino and his colleagues compared staging by DRE and TRUS 
on the basis of surgical findings. They found that of 60 tumors extending beyond the 
prostate, 92% were correctly identified by TRUS compared with only 20% by DRE. 
Finally they came to the conclusion that the predictive value of TRUS was greater than 
that of DRE in identifying those tumors that would be localized and slightly better in 
identifying which tumors were extensive [42]. On the other hand Lorentzen et al, 
investigated whether TRUS can predict the local stage of prostate cancer. They came 
to the conclusion that TRUS is probably superior to DRE as an initial staging tool, but 
TRUS of low specificity to upgrade the DRE in cases of a local stage prostate cancer 
[43]. 
TRUS aided therapies 
Throughout the 20th century, urologists have sought for an alternative to 
radical prostatectomy that would provide the same disease control without the 
associated morbidity. In this respect, among others, interstitial radiotherapy for prostate 
cancer has been investigated. Following the first reports by Young and Fronz in 1917, 
several modifications to the application of interstitial radiotherapy have been described 
[44,45,46]. An increased interest in implantation of radioactive isotopes in the prostate 
was seen when in 1982 a technique for placement of iodine seeds with ultrasound 
guidance was developed [47]. It was not until 1989 that another ultrasound aided 
therapy for the treatment of the prostate was introduced: TULIP (transurethral 
ultrasound-guided laser-induced prostatectomy) [48]. Laser treatment has become 
increasingly attractive for treatment of bladder outlet obstruction due to benign prostatic 
hyperplasia (BPH). Currently almost 20 different treatment devices are available for the 
application of laser energy to the prostate. TULIP was one of the very first laser systems 
designed for treatment of BPH. The procedure is done exclusively under transurethral 
ultrasound guidance. The advantages of such a treatment arc decreased morbidity while 
aiming for the same efficacy as transurethral resection of the prostate [49]. Because of 
the lack of direct visual control associated with the TULIP device, as well as its expense 
and relative complexity, less expensive and easier laser technologies are being 
performed [50]. 
More recently two applications of ultrasound in the treatment of prostate cancer 
have been reported on: cryosurgery of the prostate and high intensity focused ultrasound 
of the prostate. In the early sixties cryosurgery of the prostate was first performed for 
bladder outlet obstruction [51]. However, the use of prostate cyrothcrapy was limited 
by significant local complications resulting from inexact probe positioning and 
inadequate control of ablation. A means of decreasing complications emerged with the 
advent of transrectal ultrasonography. Modem ultrasound allows for precise 
percutaneous cryoprobe placement and accurate regulation of the freezing zone, 
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tissues [52]. Several promising studies are reported on, with elimination of the local 
tumor with minimal complications [52,53]. 
The ultrasound wavelength used in medicine is sufficiently short to be brought 
to a tight focus at depth within the body. This ability to focus means that both good 
resolution may be obtained in diagnostic ultrasound scans and that, if sufficient energy 
is carried by the ultrasound beam, regions of high ultrasound power are created in which 
therapeutic effects are obtained. Using high-intensity focused ultrasound (HIFU), a 
region of high energy density can be produced within tissue which can be destroyed 
without damage to overlying or intervening tissue. Initial reports on this technology in 
the treatment of prostate cancer and BPH are very encouraging [54,55]. 
Future developments 
TRUS may, besides in the therapy of prostate diseases, be applied in the 
diagnosis of prostate related abnormalities. Ultrasonography is an alternative to X-ray 
cystometry. The ultrasound image can be displayed on a monitor and recorded with 
pressures, flow, and electromyography [56,57]. In a study by Bidair et al, the 
advantages of ultrasound aided urodynamic investigations are clarified. On the other 
hand, the disadvantages of this technique should also be considered, including 
predominantly the longer learning curve [58]. 
Another diagnostic application of ultrasound is color Doppler ultrasound scanning. The 
advent of endorectal ultrasound scanning of the prostate brought hope that earlier and 
more accurate diagnosis would be possible in prostate diseases. Color Doppler 
ultrasound analysis has, in other organs and anatomic areas, added to the diagnostic 
capability of gray-scale ultrasound scanning for both the detection and distinction of 
different disease processes. Early and very preliminary results with color Doppler 
ultrasound scanning of the prostate have suggested only limited improvement on 
conventional gray-scale ultrasound in the differentiation of cancer from (benign) 
processes affecting the prostate [59]. Other investigators, however, encourage 
investigators who possess the knowledge and capability to do color Doppler studies of 
the prostate gland to do so [60]. Besides using this technique in the detection of 
prostate abnormalities, it can also be used to study the vascularization of the prostate 
and the outcome of heat treatments in patients with BPH [61] (fig 4,5). More studies 
are mandatory to decide on the value of the latter. 
Recently our group reported on the use of automated image analysis in the 
interpretation of TRUS images of the prostate [62]. To overcome the problem of 
detection of a prostate carcinoma caused by the poor hypoechogenicity of some 
carcinomas during TRUS investigations we looked for other tools and techniques. 
Image analysis techniques are already being used on a regular basis, e.g. to interpret 
satellite photography. Similar techniques have been applied in the field of medical 
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imaging Early results from these studies are very promising and therefore a similar 
concept was introduced in TRUS examinations It is our opinion that automated image 
analysis can help in the diagnosis of prostate carcinoma In patients with non palpable 
lesions or with poorly visualized tumors, image analysis is superior to the standard 
current diagnostic techniques (fig 6) 
Discussion 
Prostatic diseases have become one mam topic in the diagnosis and treatment 
in urology The incidence of benign prostatic hyperplasia is increasing with age and with 
the introduction of many alternative therapies, the demand for treatment is almost 
limitless Moreover, the prostate has become the mam site of cancer in men, with 
prostate cancer the second leading cause of death from cancer in men in the United 
States [63] To accurately make the diagnosis in the different prostate diseases, 
physicians searched for adequate tools and techniques The use of transrectal 
ultrasonography has rapidly increased since its clinical introduction Over the past 
several years, there has been much interest and enthusiasm directed toward defining 
both the value and the limitations of transrectal ultrasonography Whereas the role of 
transrectal ultrasonography in screening and early detection of prostate cancer remains 
controversial, other applications, such as assessment of prostatic size and volume, 
staging of prostate cancer, monitoring the response to therapy, and the guidance of 
prostate biopsy have received wider acceptance Also, the development of an efficient 
and non-invasive treatment for the many patients with localized cancer of the prostate 
by using HIFU or cryosurgery constitutes a considerable step forward The existence 
of a reliable gauge for the development of the cancer and the possibility of repeated 
controlled biopsies facilitate monitoring of the efficacy of the treatment Because of the 
major impact of prostate cancer on national health care and lack of highly accurate 
diagnostic techniques, we think that a significant improvement of the techniques for the 
detection of prostate cancer, such as computer analysis, will be of major clinical 
importance Further studies are on their way to decide the exact place of such an image 
analysis system 
Finally, besides the current applications of ultrasound techniques m the 
diagnosis and treatment of prostate diseases, further developments, such as temperature 
measurements using ultrasound techniques [64] will broaden the scope of ultrasound 
applications We may conclude that, although there are limitations and restrictions for 
each of the various applications, thus far transrectal ultrasound is unmatched as an 
imaging modality because of its versatility, ease of application and cost effectiveness 
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Fig. 1. A hypoechoic lesion in the right prostate lobe. Fig 2. Prostate cancer with capsular 
distortion. 
A В 
Fig. 3. Planimetrie volumetry. An image of transverse section (A) and schematic presentation of 
planimetrie method (B). 
A В 
Fig. 4. Color Doppler ultrasound study in patient before thermotherapy (A) and one hour post 
thermotherapy (B). 
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Fig. 5. Formation of a cavity in transverse ultrasound image three months post thermotherapy. 
8 
С D 
Fig. 6. Visualization of prostate cancer in a right prostate lobe. The plain ultrasound image (Л). 
Delineation by examiner of the prostate boundary (white) and prostate tumor (red) (B). Corresponding 
histological section with demarcation of tumor (red) (C). Result of image analysis where suspicious areas 
are presented (orange) (D). 
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The outcome of renal ultrasound in the assessment of 
556 consecutive patients with BPH 
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Abstract 
Purpose: We determined the additional value of renal ultrasonography in the assessment 
of patients with benign prostatic hyperplasia. 
Patients and methods: Renal ultrasound was performed in 556 consecutive patients with 
benign prostatic hyperplasia and the results were correlated with other clinical 
parameters. 
Results: Of the patients 14 (2.5%) had dilatation of the renal pelvis, 65 ( 11.7%) renal 
cysts and 1 (0.18%) patient with a renal cell carcinoma. The serum creatinine level 
appeared to be correlated with dilatation of the renal pelvis. To predict dilatation, 
additional information can be obtained by adding the results of the post voiding residual 
measurements. 
Conclusion: Renal ultrasound is only indicated in patients with a specific serum 
creatinine level and/or post-void residual volume. 
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Introduction 
Each patient suspected clinically of suffering urinary problems secondary to 
benign prostatic hyperplasia (BPH) should undergo screening investigations, including 
assessment of the renal function For decades excretory urography (IVU) was performed 
in these patients to exclude upper urinary tract pathology The IVU reliably 
demonstrated renal cortical abnormalities, upper tract dilatation and the presence of 
nephrolithiasis However, a few years ago, the efficacy of an IVU in the assessment of 
uncomplicated BPH was questioned in that it is a relatively expensive procedure, it is 
time-consuming, and requires use of ionizing radiation and contrast medium, side 
effects may develop and treatment policy seldom is changed afterwards [1-3] 
With introduction of ultrasonography, it was recognized that this cheaper and 
less invasive method demonstrated accurately the condition of the upper urinary tract 
With careful scanning technique and interpretation, ultrasonography is a very sensitive 
detector of upper tract distension Moreover renal cortical abnormalities, such as renal 
cysts or a kidney tumor, as well as nephrolithiasis, may be detected by renal ultrasound 
Several investigators showed that a combination of renal ultrasound, plain abdominal 
X-ray, urinalysis and scrum creatinine could replace the intravenous urography m the 
assessment of patients with BPH [4-6] Consequently ultrasonography is recommended 
as a first choice procedure when upper urinary tract imaging is indicated before therapy 
The treatment of BPH is currently being reevaluated and numerous alternative 
therapies are being introduced In combination with changes m social habits and 
increasing life expectancy the demand for therapy is almost limitless Consequently the 
costs involved in assessment and therapy increase rapidly and authorities stress wise use 
of available resources 
To determine the additional value of standard ultrasonographic imaging of the 
upper urinary tract we evaluated the outcome of renal ultrasound examinations 
performed in 556 consecutive patients with lower urinary tract symptoms and BPH 
Moreover, we provide recommendations for the use of renal ultrasound in these patients 
Patients and Methods. 
A total of 556 consecutive patients with lower urinary tract symptoms and BPH 
underwent a complete standardized prctreatment screening consisting of history taking 
(including symptom score) and physical examination with digital rectal examination, 
urinalysis, serum creatinine and PSA measurement, transrectal ultrasonography of the 
prostate, flexible urethrocystoscopy, uroflowmetry with post-void residual volume 
measurements via transabdominal ultrasound, urodynamic investigation, plain 
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abdominal X-ray and renal ultrasound. During the initial visit, before history and 
physical examination, blood was drawn and a midstream urine specimen was collected. 
Transrectal ultrasound was performed by an experienced urologist using a Kretz 
Combison 330 ultrasound scanner with a transrectal probe (VRW 77AK multiplane 3-
dimensional rectal transducer). Longitudinal and transverse prostate images were 
recorded to judge the presence of abnormalities and to measure the prostate volume 
using a planimetrie method. If any abnormality was found during transrectal ultrasound 
of the prostate, digital rectal examination and/or at PSA determination, ultrasound 
guided prostate biopsies were obtained to exclude malignancy. 
The same ultrasound scanner was used in combination with a transabdominal 
probe (Kretz AWP 3.5) to image both kidneys. During ultrasonography the presence of 
hydronephrosis, nephrolithiasis and cortical lesions was evaluated. If such an 
abnormality was detected, the patient was referred to the department of radiology for 
further complementary and detailed imaging. Dilatation of the renal pelvis on 
ultrasonography was classified as slight-renal pelvis enlarged just beyond normal size, 
moderate-dilated calices present and severe-grossly enlarged renal pelvis and clubbed 
calices (figures la-d). Furthermore, the presence of renal cysts, concrements or other 
renal masses was documented. 
During the second visit full urodynamic investigations were performed after 
free uroflowmetry via an 8F transurethral lumen catheter with an intravesical microtip 
pressure sensor. The pressure and flow data were recorded and stored with equipment 
developed at our department. To obtain useful information from pressure-flow curves 
it is necessary to relate detrusor pressure to the corresponding flow. Schäfer presented 
the concept of a classification system (Linear-Passive-Urethral-Resistance-Relation, L-
PURR), connecting minimal opening pressure with pressure at maximal flow. This 
concept was used to classify bladder outlet obstruction as minimal (grades 0 to 2), 
moderate (grades 3 and 4) and severe (grades 5 and 6). Finally, flexible 
urethrocystoscopy was performed to judge the patency of the urethra, evaluate the 
configuration of the prostatic urethra and inspect the bladder for abnormalities. 
The results obtained during ultrasonography were correlated with all other 
parameters previously described. For database management we used software developed 
at our urological centre. Differences between groups were evaluated with the chi-square 
test, with p-value < 0.05 considered statistically significant. 
Results 
The patient age ranged from 42 to 91 years (mean age 64.4), and the history 
revealed complaints at least three months in duration by all patients based on the 
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International Prostate Symptom Score (average 17 5, ranged 1 to 35) Average prostate 
volume as measured by transrectal ultrasound was 43 7 cm3 (range 12 to 160) Renal 
ultrasonography demonstrated abnormalities in 14 2% of the patients (table 1), the 
majority of which were renal cysts (65), followed by dilatation (14) and a renal tumor 
(1) A more detailed evaluation revealed dilatation of the renal pelvis, which was slight 
in 42 8% of patients, moderate in 35 7% and severe in 21 4% 
Table 1. Findings at renal ultrasound 
Normal 
Abnormal 
Abnormalities 
Dilatation 
Cysls 
Tumor 
Dilatation* 
Slight 
Moderate 
Severe 
*Slight in 6 patients (42 8%), moderate in 5 patients (53 7%) and severe in 3 (21 4%) 
When the different screening modalities were correlated with dilatation of the 
renal pelvis, scrum creatinine appeared to be a good criterion to predict the presence of 
dilatation The serum creatinine of the whole group ranged from 68 to 328 цтоі/і 
(average 98 цтоі/і, normal 62 to 110) compared to 84 to 250 цтоі/і (average 142) in 
patients with dilatation of the renal pelvis Analysis revealed two cutoff points for 
serum creatinine values, correlating with a high prevalence of dilatation Only 4 patients 
with serum creatmine less than 115 цтоі/і, had dilatation (3 slight and 1 moderate), 
compared to 10 of 53 (18 9%) with serum creatinine above 115 цтоі/і (3 slight, 4 
moderate and 3 severe) Of 21 patients with a serum creatinine more than 130 μπιοΙ/1 
7 had dilatation on the renal ultrasound (3 severe, 3 moderate and 1 slight) There 
appeared to be no correlation with patient age, prostate size and the grade of bladder 
outlet obstruction or symptoms (table 2) 
The post-void residual unne volume ranged from 0 to 1250 ml (average 77 6) 
Further analyses showed that dilatation of the renal pelvis was closely related to the 
outcome of this investigation in combination with the serum creatinine level To 
decrease the number of unnecessary renal ultrasound studies in the 32 patients whose 
477 
79 
14 
65 
1 
6 
5 
3 
(85 8%) 
(14 2%) 
(2 5%) 
(117%) 
(0 2%) 
(42 8%) 
(35,7%) 
(21,4%) 
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serum creatinine was 115 to 130 цтоІЛ, the post-void residual unne was also 
measured It appeared that in this subgroup all patients with dilatation presented cither 
with a urinary retention (1) or post-void residual urine volume larger than 150 ml (2) 
Based on the aforementioned entena the number of ultrasound studies performed could 
be decreased from 556 to 31 (5 6%) Thus, 3 patients with slight and 1 with moderate 
dilatation would be missed Moreover, nephrolithiasis occurred in 49 patients, and was 
sometimes visualized during ultrasonography No patients with dilatation of the renal 
pelvis had urolithiasis 
Discussion 
Until the early eighties an IVU before treatment of unnary outlet obstruction 
in patients with BPH was advocated as a first choice method of screening the (upper) 
unnary tract However, several studies have demonstrated that 73-92 2 % of the patients 
with lower unnary tract symptoms have a normal IVU, with hydronephrosis being the 
most common reported abnormality in 3-13% [1,6,7] Because hydronephrosis may 
cause renal impairment, this finding can influence the treatment approach and therefore 
hydronephrosis is obviously the most important condition to be excluded This fact and 
that an IVU involves radiation exposure plus the risk of possible allergic reactions to 
intravenous contrast matenal question the necessity of urography m cases of 
uncomplicated BPH [3] Moreover this investigation lacks ready availability, and is time 
consuming and uncomfortable to the patient Matthews et al elegantly demonstrated that 
ultrasonography could very well replace IVU to detect most abnormalities in 
uncomplicated cases [6] Lihenfeld et al suggested replacement of urography by a 
combination of renal ultrasound, plain abdominal X-ray, urinalysis and blood urea 
nitrogen determination [4] The combination of blood biochemical evidence of renal 
impairment and the presence of hydronephrosis in patients with BOO was also shown 
by Marshall et al [8] Logically several investigators have questioned the need of 
preoperative imaging procedures at all in uncomplicated cases [2,9] 
We evaluated the efficacy of a standard transabdominal ultrasound 
investigation of the kidneys, performed by a urologist expenenced with 
ultrasonography, before treatment of BPH Ultrasound results were abnormal in 14 2% 
of cases, similar to the study of Fidas et al who noted an abnormality in 16% of cases 
with hydronephrosis being the most important finding [10] 
From our study we learned that routine ultrasonography of the kidneys in all 
patients would be unrewarding investigation the majority Cntena for selecting patients 
for renal ultrasound are needed to limit the number of ultrasounds and subsequently 
reducing costs without the nsk of missing clinically relevant pathology of the upper 
urinary tract Analysis of parameters used in the assessment of patients with BPH 
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showed that the serum creatinine may be used as an indicator for renal impairment and 
could be a useful selection criterion for performing renal ultrasound All but 2 patients 
with a serum creatinine less than 115 μπιοΐ/ΐ had no clinically significant renal 
pathology on ultrasound Renal cysts and slight dilatation of the renal pelvis are not 
considered clinically significant pathology since their presence docs not change 
treatment policy and they apparently do not cause renal impairment within a short 
period [10] In 1 patient a lesion suspect for renal cell carcinoma was found (0 18%), 
and was confirmed by nephrectomy In this patient none of the other assessment 
parameters indicated the presence of the renal malignancy, thus making it a coincidental 
finding in accordance with the incidence rate of renal cell carcinoma in the general 
population [11] Performing renal ultrasound only in patients with a scrum creatinine 
higher than 115 μπιοΐ/ΐ revealed all but one clinically significant dilatation of the renal 
pelvis The missed patient appeared to have preexisting hydronephrosis not caused by 
urinary outlet obstruction and without impairment of renal function To diagnose all 
relevant dilatations of the renal pelvis with a minimum of renal ultrasounds studies we 
analyzed the number of dilatations in patients with a serum creatinine greater than 115 
цтоІЛ and PVR or unnary retention In patients whose scrum creatinine was 115 to 130 
μπιοΐ/ΐ a post voiding residual larger than 150 ml or urinary retention provided 
additional information to perform renal ultrasound With these selection criteria the use 
of renal ultrasound decreased from 53 to 31 studies performed without missing a 
clinically significant dilatation of the renal pelvis When serum creatinine was greater 
than 130 цтоі/і, significant dilatation occurred in a considerable number of patients, 
making routine renal ultrasound scanning in these patients mandatory Although there 
were few patients with hydronephrosis, a chi-square test showed a statistically 
significant difference (p<0 0001) between the creatinine value and the presence of 
hydronephrosis 
The outcome of our investigation has changed the policy at our department for 
performing routine ultrasound of the kidneys in patients with uncomplicated BPH We 
now only perform this imaging procedure in patients with a serum creatinine greater 
than 130 цтоі/і or with a level of 115 to 130 цтоі/і plus a post voiding residual larger 
than 150 ml or urinary retention at presentation to the outpatient clinic Using these 
criteria we decreased the percentage of non contributory renal ultrasounds by 94 4% 
With these entena there is the possibility that a coincidental renal malignancy, for 
example as noted in one of our patients, may be missed However, we believe that the 
incidence of renal malignancy m our patient group (<0 2%) does not justify the 
performance of a renal ultrasound to exclude upper urinary tract pathology in all 
patients with uncomplicated BOO Moreover, we concluded that in view of our results 
there is only limited use for performing an IVU This opinion is endorsed by other 
investigators who reject standard IVU being performed in uncomplicated cases just 
because of curiosity, habit or tradition [11] Of course any complicating factors, such 
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as haematuria or a positive medical history for urologie disease such as renal stones, 
justify the use of I VU. However, in all other cases it remains the sole responsibility of 
the treating urologist to decide on upper urinary tract imaging in the assessment of 
patients with lower urinary tract symptoms and BPH. 
Conclusions 
Renal ultrasound to exclude upper urinary tract pathology in patients with 
bladder outlet obstruction and BPH will provide additional information only if the 
serum creatinine is greater than 130 цтоі/і. For scrum creatinine levels of 115 to 130 
цтоі/і renal ultrasound is advocated if a post void residual volume larger than 150 ml 
or bladder retention is present. 
Table 2. Correlation among serum creatinine level, presence of renal pelvis dilatation and 
other clinical prameters 
Creatinine No. Dilatation* Age* IPSS* Prostatevol.**L-PURR** 
{μ mol /1) (%) (cm3) 
<115 503 4(08%) 639±847 17.5±704 4 2 9 ± 2 0 3 6 2 5± 1 59 
115-130 132 3(9 3%) 68 2 ± 8 99 16 9± 6 57 54 8±27 75 2 7 ± 1 73 
a 130 217 (33 3%) 69 2 ± 7 85 20 8 ± 8 65 47 0 ± 2 3 88 2.5±2 14 
Total 556 14(2 5%) 64 4 ± 8 57 17 5 ± 7 07 43 7 ±21 18 2 6 ± 1 6 2 
*p<0 0001 
* * N S 
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Figure 1. Transabdominal ultrasound of the kidney. 
A: Normal kidney, no dilatation. 
B: Slight dilatation of the renal pelvis which is just visible. 
C: Moderate dilatation of the renal pelvis. Note the grossly enlarged pyelum without 
involvement of the calices. 
D: Severe dilatation of the renal pelvis. Involvement of the calices which are dilated and 
clubbed. 
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The correlation between urodynamic and cystoscopic Findings in 
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Abstract 
Purpose: We evaluated the urethrocystocopic findings and results of urodynamic studies 
in elderly men with voiding complaints. 
Material and Methods: A total 492 consecutive patients with voiding complaints 
underwent a standardized screening program including transrectal ultrasonography of 
the prostate, urodynamic investigations with pressure-flow study analysis, and flexible 
urethrocystoscopy. 
Results: A significant correlation was found between bladder trabeculation and grade 
of bladder outlet obstruction. Detrusor instability correlated significantly with the grade 
of trabeculation. Grade of obstruction showed a clear correlation with prostatic 
occlusion of the urethra and the presence of middle lobe at cystoscopy. 
Conclusion: The findings at urethrocystoscopy correlate well with the findings at 
urodynamic investigations. 
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Introduction 
For many years the diagnosis and management of voiding complaints m elderly 
men were straight forward Surgical techniques for removing the obstructive prostatic 
tissue relieved symptoms in most men and much of debate focused on the relative value 
of open prostatectomy versus transurethral resection However, with the advent of the 
medical and less mvasive treatment modalities for the treatment of bladder outlet 
obstruction, it has become necessary to know more about the etiology and pathology of 
the disease [1] It is well known that the evaluation and treatment of voiding complaints 
in elderly men are a primary endeavors of the urologist and lead to the surgical 
procedures listed in the urological armamentarium [2] Also, voiding complaints in 
elderly men are most frequently caused by benign prostatic hyperplasia (BPH) which 
develops with increasing frequency as men age The resulting prostatic growth has a 
critical role in altering voiding, which results in significant (pathological) changes in the 
urinary tract of some patients and symptoms alone in others On the other hand, the role 
of BPH m the voiding dysfunction experienced by elderly men is often unclear [3] 
Hyperplasia may be associated with striking lateral lobe enlargement but symptoms 
may be negligible if the degree of obstruction is not severe Conversely BPH may be 
associated with a relatively small sized prostate and marked obstructive symptoms if 
the obstructing tissue originates exclusively within the central zone of periurethral gland 
area [4] Although the pathophysiology of benign prostatic hyperplasia and its effect on 
the bladder wall is not completely understood, we agree that when the bladder passes 
through the stages of irritability, compensation and decompensation outlet obstruction 
may occur In response to outlet resistance, hypertrophy of the detrusor muscle 
commences and trabeculation may develop [5] 
On the other hand, urethrocystoscopy provides information as to the cause, 
size, severity of obstruction, patency of the bladder neck, prostatic occlusion of the 
urethra and the estimated prostatic size |2] The gold standard to measure bladder 
outlet obstruction is by urodynamic investigations with pressure-flow studies [6] 
Although the diagnosis and treatment of BPH are common subjects, only limited 
information is available regarding the correlation between urethroscopic findings and 
urodynamic studies [7] Turner-Warwick et al concluded that the endoscopic appearance 
of trabeculation in men is usually associated with a thick walled bladder but is not 
diagnostic for obstruction, and that the most common correlation is noted with unstable 
detrusor function which may or may not be associated with obstruction f 8] Andersen 
and Nordhng concluded in their study that urethrocystoscopy gives good information 
of the site and seventy of the obstruction [9] Recently, Madsen and Bruskewitz 
concluded that urethrocystoscopy has a limited role in the evaluation of BPH However, 
they mentioned that available data suggest that bladder trabeculation in BPH is a 
predictor of the treatment outcome, and that cystoscopy might be performed before 
invasive therapy to guide the urologist in choosing an operative approach [10] 
72 Chapter 6 
We evaluated the findings of urcthrocystoscopy compared to those of the 
preceding urodynamic studies to determine whether trabeculation and prostatic 
enlargement indicate bladder outlet obstruction, whether an enlarged middle lobe 
correlates with increased outlet resistance, and whether there is a relationship between 
bladder trabeculation and instability. 
Material and methods 
A total of 492 consecutive patients with voiding complaints underwent a 
standardized screening program, including history, physical and digital rectal 
examinations, biochemistry studies (prostate specific antigen), urinalysis and culture, 
urine cytology, transrectal ultrasonography of the prostate, urodynamic investigations 
and flexible urcthrocystoscopy. Prostatic size was determined using an ultrasound 
scanner with a 7.5 MHZ transrectal probe. The prostate was imaged from base to apex, 
documenting the presence of prostate abnormalities and measuring the prostate volume 
using the planimetrie method [11]. Urodynamic investigations were performed using an 
8F transurethral lumen catheter and an 8F transrectal catheter, both were equipped with 
a microtip pressure sensor. Before cystometry the bladder was emptied through the 
lumen of the transurethral catheter to quantify residual urine after free uroflowmetry. 
The pressure sensors were zeroed to atmospheric pressure before introduction. The 
bladder was filled with water of 20°C with a filling speed of 50 ml/min with the patient 
supine. Filling was stopped when the patient expressed a strong urge to void, and 
micturition while standing was allowed in private. The digitally stored data were 
analyzed with equipment developed at our department. 
To obtain useful information from pressure-flow study curves, it is necessary 
to relate detrusor pressure to the corresponding flow. To quantify the grade of outlet 
obstruction, the concept of the linear-passive urethral resistance relation (lin-PURR), 
connecting minimal urethral opening pressure with pressure at maximum flow, was used 
[ 61. Classes 0 and 1 of this scale indicate no, classes 2 and 3 moderate, and higher 
classes severe bladder outlet obstruction on urodynamic study. Another method of 
grading bladder outlet obstruction is with the urethral resistance factor (URA), which 
is calculated based on the point of maximum flow and corresponding detrusor pressure 
[12]. A URA value >29 cm H20 indicates obstruction. Finally, the minimal urethral 
opening pressure (pmuo) and theoretical urethral lumen (Atheo) were calculated on the 
basis of the PURR curves, adjusted to the lower pressure part of the pressure flow graph 
[13]. The investigations were completed by urethrocystoscopy. 
The studies were done with the patient under local anaesthesia. A flexible Storz 
urethrocystoscope was used to evaluate the entire bladder surface with special attention 
to bladder trabcculalions, which were classified 0=none, l=slight to moderate, 2=severe, 
3=scvcre with formation of (pseudo) diverticula. Moreover, the appearance of the 
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bladder neck was described, and the degree of prostatic occlusion of the urethra as well 
as the distance from the bladder neck to vcramontanum were reported Prostatic 
occlusion was graded as l=no, 2=moderate, and 3=severe obstruction (fig 1) Also the 
presence of a high and narrow bladder neck, and the presence of a middle lobe were 
documented Patients with urethral strictures, prostate cancer or bladder abnormalities 
such as bladder stones, were excluded from this study since these diseases were believed 
to be the predominant cause of the symptoms 
For statistical analysis Kruskal Wallis and Chi Square correlation tests were used 
Results 
Mean patient age was 64 8 years (range 42 to 89), and the prostate volumes 
ranged from 13 to 127 cm3 (mean 44 7± 20) The grade of trabeculation was correlated 
with the clinical parameters (in table 1) Of the patients 12% had a grade 0, 58% grade 
1, and 23% grade 2 and 7% grade 3 trabeculation An increase of trabeculation is 
noticed in patients with larger prostates The total I-PSS symptom score also increased 
slightly with higher grade of trabeculation but without significant statistical correlation 
Table 1 Correlation between the grade of trabeculation and clinical parameters 
noofpts 
agC (years) 
0 
59 
ï 62 7 
IPSS(iot)*17 2 ± 6 3 
filling 
voiding 
VlTldX 
(ml-s)* 
pros vol 
(βπΟ* 
residue 
(ml)* 
6 8 ± 3 7 
1 0 3 ± 3 6 
11 3 ± 4 5 
3 8 ± 15 
56 ± 1 2 7 
Trabeculation grade 
1 
283 
64 7 
17 5 ± 6 5 
7 5 ± 3 5 
9 9 ± 3 7 
1 1 6 ± 6 5 
43 ± 1 7 5 
59 ± 1 0 0 
2 
113 
66 1 
1 8 7 ± 6 9 
8 5 ± 3 9 
1 0 4 ± 4 8 
9 8 ± 4 2 
53 ± 2 6 
86 ± 1 1 3 
3 
37 
67 1 
20 4 ± 6 3 
8 8 ± 3 6 
11 6 ± 3 6 
6 9 ± 3 9 
45 ± 1 9 
142 ± 1 7 2 
Ρ value 
NS 
NS 
0 05 
NS 
O 0 0 0 1 
<0 0001 
О 0001 
Q max (ml/s) maximum flow rate, IPSS- international prostate symptoms score 
Filling symptoms Total score of questions 2,4 and 7 of the I-PSS 
voiding symptoms Total score of questions 1, 3, 5 and 6 of the I-PSS 
* Mean plus or minus standard deviation. 
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1 
Figure 1. Cystoscopic appearance regarding bladder trabeculation (0 non, 
l=shght/moderate, 2=severe, 3=severe with formation of diverticula) and prostatic occlusion 
(1 =not obstructed, 2 =moderately obstructed, 3=severely obstructed). 
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On the other hand, the filling component of I-PSS (the total score of questions 
2,4 and 7) correlates weakly with trabeculation Also the maximum flow rate and post 
void residual volume showed a significant correlation with trabeculation Uroflowmctry 
results for the entire group showed an average maximum flow of 10 8 ± 5 8 ml/s with 
post void residual volume of 70 ± 114 ml There was a decrease in maximum flow rate 
and an increase in the post void residual volume with higher grades of trabeculation 
The pressure-flow study parameters also showed significant correlations with 
trabeculation With increasing grade of trabeculation, Pdet Qmax, hn-PURR, URA, and 
pmuo increased (table 2) These correlations were statistically significant Other 
urodynamic parameters, such as Aiheo correlated significantly with inverse relation with 
trabeculation The cystometnc capacity worsen with increasing grade of trabeculation 
but this was not statistically significant The relationship between the grade of bladder 
trabeculation and the seventy of bladder outlet obstruction is shown in figure 2 We 
conclude that an increase of trabeculation significantly correlates with an increase in 
bladder outlet obstruction 
Table 2 Correlation between the grade of trabeculation and the mean value of urodynamic 
parameters 
Trabeculation grade 
•*dct V max 
(cm H20) 
URA 
(cm H20) 
Pmuo 
(cmHjO) 
Aheo 
(mm2) 
Capacity 
(ml) 
Compliance 
0 
41 3 ± 20 7 
29 6 ± 16 7 
187 ± 12 1 
41 ± 27 
406 ± 121 
38 1 ± 3 2 9 
(ml/H20) 
lm-PURR(mode) 1 
1 
51 1 
32 8 
25 2 
36 
400 
30 3 
± 
± 
± 
± 
± 
± 
23 1 
152 
159 
22 
126 
35 9 
2 
2 
67 7 ± 
45 5 ± 
33 8 ± 
25 ± 
386 ± 
27 5 ± 
23 2 
167 
168 
16 
143 
33 1 
4 
3 
87 7 ± 
60 7 ± 
40 5 ± 
2 0 ± 
353 ± 
37 1 ± 
32 6 
23 6 
20 3 
26 
149 
55 7 
4 
Ρ Value 
<0 0001 
<0 0001 
<0 0001 
O0001 
NS 
<0 05 
<0 0001 
Ρ da Qmm (cm ¥ Ο)= detrusor pressure at maximum flow, URA (cm HO)= Urethral 
Resistance Factor, pP
ml0 (cm ЦО)= minimal voiding pressure, ¡fò (mm2) - theoretical 
urethral lumen, lin-PURR= linear-Passive Urethral Resistance Relation 
76 Chapter 6 
100 
60 
60 
S 40 
20 
[ J linPURR>3 
^ ImPURR 2-3 
• lmPURR<2 
1 2 
Trabeculation Grade 
100 
В 
2 40 
| | grade 3 
• grade 2 
£3 grade 1 
| grade 0 
hnPURR<2 hnPURR>3 
Figure 2. Correlation between the grade of trabeculation and grade of bladder outlet 
obstruction according to linear passive urethral resistance relation (lin-PURR). 
Detrusor instability was noted in 74 patients, and there was a good correlation 
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between the grade of trabeculation and detrusor instability (table 3). Of the patients 112 
had a small middle lobe and 48 patients a large middle lobe. With the presence of a 
middle lobe, there appeared to be a tendency towards increased grade of obstruction 
according to lin-PURR (figure 3). The correlation between the prostate size, measured 
by transrectal ultrasound, and trabeculation was less pronounced (figure 4). However, 
there appeared to be a good correlation between the grade of prostatic occlusion, 
estimated at urethrocystoscopy, and grade of outlet obstruction (P< 0.0001, figure 5). 
Table 3. Correlation between the grade of trabeculation and detrusor instability. 
Trabeculation grade 
0 1 2 3 Total 
instability 5(8.5%) 35(12.4%) 18(15.9%) 16(43.2%) 74(15%) 
stable 54(91.5%) 248(87.6%) 95(84.1%) 21(56.8%) 418(85%) 
Discussion 
Among the urological community it is generally believed that voiding 
complaints in elderly men are caused most frequently by BPH. Indeed, for many years 
the diagnosis and management of this disease aimed at removing the obstructive 
prostatic tissue. During the last years, however, research has led to the understanding 
that so called BPH is not a single disease but one characterized by heterogenicity. The 
pathophysiology of the disease varies in the nature of the mechanical obstruction, for 
example lateral, middle or trilobar hyperplasia, the degree of dynamic obstruction and 
the response of the detrusor musculature. The rings of Hald provided a sound basis in 
which the pathophysiology is divided into three parts: lower urinary tract symptoms, 
prostate size and bladder-outlet obstruction [14]. Despite the existence of an increasing 
number of reports on the relationship between prostate size, and obstruction, a defined 
correlation between the pathophysiological components remains unproved [15,16,17]. 
Docs there really exist a good correlation between the urethrocystoscopic findings and 
the results of the pressure flow studies? Is the finding of trabeculation correlated with 
worsening of the bladder function? Does trabeculation correlate with bladder 
instability? 
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Figure 3. The correlation between the presence of middle lobe and grade of bladder outlet 
obstruction according to lin-PURR. 
100 
60 
s 60 
S 40 
20 Ш 
Π >60cm3 
g^ 30-60 cm3 
Ш <30стЗ 
1 2 
Trabeculation Grade 
Figure 4. The correlation between the grade of trabeculation and prostate size measured by 
transrectal ultrasound. 
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We showed unequivocally that a correlation between the presence of a middle 
lobe and the grade of bladder outlet obstruction. Moreover, the obstruction 
classification of the prostate at cystoscopy seems to correlate even better with the grade 
of bladder outlet obstruction than the measurement of the prostate volume alone. We 
agree with Andersen and Nordling that urethrocystoscopy also provides good 
information on the site as well as the hydrodynamic severity of organic infravesical 
obstruction [9]. Indeed, the urodynamic parameters of bladder outlet obstruction judged 
by the pressure flow parameters were significantly correlated to the urethrocystoscopic 
findings of prostatic occlusion of the urethra, and the presence of a middle lobe. 
100 
£ 40 
D linPURR>3 
linPURR 2-3 
linPURR<2 
Figure 5. The correlation between the grade of prostatic occlusion(]~not obstructed, 
2=moderately obstructed, 3=severely obstructed) and bladder outlet obstruction according 
to lin-PURR 
At cystoscopy, many urologists attempt to evaluate the degree of obstruction 
by assessing bladder trabeculation. However, to our knowledge no studies have shown 
a significant association between bladder trabeculation and the severity of obstruction 
[9,18]. In the male the detrusor muscle reacts to outlet obstruction in a variety of ways 
and not all detrusors are equal. The presence of bladder trabeculation, and (pseudo) 
diverticula has traditionally been regarded as signs of compensatory bladder 
hypertrophy. Chappie and Turner Warwick conclude that the endoscopic appearance of 
trabeculation in the male is usually associated with a thick walled bladder but neither 
is diagnostic of obstruction [19]. Our results showed that there is good correlation 
between the grade of trabeculation and the grade of bladder outlet obstruction. For the 
individual patient, however, one cannot make the same conclusion. Moreover, we are 
aware that grading of trabeculation is physician dependent. Some researches stated that 
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trabcculation appeared to correlate with collagen deposition, rather than muscular 
hypertrophy, although both of these processes appear to occur m obstructed bladders 
[20,21 J However, sequence of hypertrophy and collagen deposition is not clear, and 
some discrepancies in the findings related to the presence or absence of muscular 
hypertrophy and collagen deposition may reflect the stage of development of detrusor 
changes in relation to obstruction In contrast with the findings of Andersen and 
Nordhng, our study shows a clear correlation of detrusor instability with grade of 
trabeculation [9] 
We agree with Elbadawi et al that it remains to be determined whether 
overactivity and trabcculation represent a cause and effect relationship or are 
independent manifestations of the same process that initiates structural changes in the 
aging detrusor in general [22] They attempt to define structural and urodynamic 
grouping of patterns with prognostic, predictive potential m various forms of voiding 
dysfunction There seems to be good correlation between the ultrastructure features of 
the structural patterns and matching urodynamic findings Widespread degeneration of 
muscle cells and axons is proposed as the structural correlate of impaired detrusor 
contractility in the aging detrusor 
The lack of strong relationship between urological symptoms, and anatomical 
and physiological measures of BPH severity has been described by others [23,24] Our 
study confirmed this presumption only partially It appeared that the filling component 
of the symptom scores correlated significantly with the grade of bladder trabeculation 
An explanation for this finding may be that with an increase in the bladder outlet 
obstruction an increase in the number of patients with bladder instabilities can be found 
Finally, what is the implementation of our findings in daily clinical practice? 
A considerable number of urologists still depend on cystoscopic rather than urodynamic 
findings in the diagnosis bladder outlet obstruction because they do not have 
urodynamic equipment at their disposal or are not used to performing urodynamics in 
patients with BPH However, for the individual patient with normal cystoscopic 
findings, bladder outlet obstruction is still present in about 15% of patients (figure 2 A) 
On the other hand, if severe trabeculation is present, about 8% of patients are not 
obstructed at all 
In conclusion generally the findings at urethrocystoscopy correlate well with the 
results of urodynamic investigations For the individual patient, however, one cannot 
make the same conclusion In response to several different etiological factors, the 
bladder wall undergoes distinct morphological changes that are readily recognized 
macroscopically as trabeculation Whether trabcculation is associated with bladder 
dysfunction with irreversible changes at cellular level or simply a sign of reversible 
compensation due to bladder obstruction remains unclear 
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Abstract 
Purpose To study the relation between lower unnary tract symptoms (LUTS), as 
measured by the International Prostate Symptom Score (I-PSS), and urodynamic 
findings in elderly males Material and methods 803 consecutive patients with LUTS 
were evaluated with the I-PSS symptom score and a urodynamic investigation with 
pressure flow studies 
Results A statistical significant correlation was found between all questions of I-PSS 
(except mlermittency) and objective parameters of obstruction However, the clinical 
significance of this finding is minimal, because there exists a huge overlap of symptom 
score between patients with different grades of BOO The filling component of the I-
PSS symptom score correlated somewhat better with obstruction than the voiding 
component 
Conclusion From symptoms alone, it seems impossible to diagnose BOO It appears 
not even possible to define subgroups m whom further urodynamic examination is 
indicated 
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Introduction 
Male bladder outlet obstruction (BOO) due to benign prostatic hyperplasia 
(BPH) has presented a clinical problem throughout medical history. It has been 
estimated that BPH affects approximately 50% of men aged 60 [1 J. By age 80, some 
estimates the prevalence at approximately 80% [2]. The incidence and clinical 
significance of BPH has been increasingly difficult to evaluate as the indications for 
medical intervention have been shifted from attempts to preserve life, to attempts to 
improve quality of life. As the emphasis has shifted from the effect of BPH and its 
sequelae on the length of life to earlier treatment of bothersome complaints, the 
incidence of BPH related symptoms affecting maintenance of a normal or reasonable 
life style has assumed increasing importance. Also, as we move into an era where 
alternatives to surgery are increasingly used in the treatment of BPH, the time has come 
to consider the minimum diagnostic criteria that should be established before any 
treatment, either medical or surgical, is recommended. 
It is a central concept in urology that BPH causes prostatic enlargement, which 
in turn may lead to BOO and development of LUTS. Therefore clinical BPH has been 
characterized by the combination of three parameters: the presence of lower urinary 
tract symptoms (LUTS), the presence of bladder outlet obstruction (BOO) and 
increased prostate volume due to hyperplasia [3]. Treatment policy is based on 
symptoms to relieve BOO. Moreover, the best indicator of successful treatment still is 
relief of symptoms. It is unclear if, in the absence of symptoms, downgrading of BOO 
should be considered as an additional indicator of treatment success. The gold standard 
to evaluate the grade of BOO is urodynamic studies with pressure flow analysis |4]. 
Because of the invasive nature of these studies they are seldom performed and, 
consequently, only limited data is available to answer this question. 
Several symptom scores have been developed to assess severity of symptoms 
in a more formal way [5-8]. In 1992 the AUA symptom score was published and this 
has been endorsed by the World Health Organization as the International Prostate 
Symptom Score (I-PSS)(page, 27) [9]. It has been integrated into the evaluation of 
patients with LUTS (caused by BPH) and has been recommended as a valid tool to be 
used in the diagnosis of BOO in these patients [10]. 
Despite an increasing number of publications on the relationship between 
LUTS and BOO, the correlation between the two remains unproven [11,12 ]. Most 
urologists agree that only patients with BOO should be treated by surgical intervention. 
Nevertheless, the decision for surgical management is usually based primarily on the 
nature and severity of presenting symptoms. The relationship between symptoms and 
BOO is therefore an important issue. We conducted a study on a large series of patients 
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with LUTS aiming to delineate the relation between preoperative voiding symptoms 
using the I-PSS symptom score and urodynamic findings 
Material and methods 
We studied 803 consecutive patients with LUTS and/or BPH All patients 
included in the present study were subjected to a standardized diagnostic program 
consisting of history (including the I-PSS), physical examination (including digital 
rectal examination), biochemistry (including PSA), urinalysis and culture, urine 
cytology, and urodynamic investigations including pressure flow studies Patients with 
a total I-PSS symptom score < 8 were considered to have mild symptoms, patients with 
a score of 8-19 were considered to have moderate symptoms, and patients with I-PSS 
> 19 were considered to have severe symptoms [ 12] The total score of I-PSS questions 
2,4, and 7 represents the filling component of the I-PSS symptom score, while the total 
score of questions 1, 3,5, and 6 represents the voiding component 
Urodynamic investigations were performed using an 8F transurethral catheter 
and an 8F transrectal catheter Both were equipped with a microtip pressure sensor 
(MTC, Drager, The Netherlands) Before cystometry the bladder was emptied through 
the lumen of transurethral catheter m order to quantify residual urine after free 
uroflowmetry The pressure sensors were zeroed to atmospheric pressure before 
introduction The bladder was filled with water of 20°C with a filling speed of 50 
ml/min with the patient in supine position Filling was stopped when the patient 
expressed a very strong urge to void and micturition in standing position was allowed 
in private The digitally stored data were analysed with equipment developed at our 
department (UIC/BME Research center, Department of Urology, Nijmegen, The 
Netherlands) In order to get useful information from pressure-flow study curves, it is 
necessary to relate detrusor pressure to the corresponding flow To quantify the grade 
of BOO, the concept of the Linear-Passive Urethral Resistance Relation (linPURR), 
was used [4] Patients in classes 0 and 1 of this scale do not have any urodynamic 
obstruction Patients in classes 2 and 3 are considered to have moderate BOO and 
patients in higher classes have severe obstruction Another method of grading bladder 
outlet obstruction is by using the Urethral Resistance Factor (URA) Calculation of 
URA is based on the point of maximum flow and corresponding detrusor pressure [13] 
A URA value >29 cm H20 indicates obstruction Finally the minimal urethral opening 
pressure (pmuo) was calculated on the basis of the PURR curves, adjusted to the lower 
pressure part of the pressure flow graph [ 14] 
For statistical analysis we used descriptive statistics and the Spearman 
correlation coefficient to describe the association between I-PSS questions and the 
various urodynamic parameters 
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Results 
Descriptive statistics with respect to the patients' age, prostate volumes, and 
urodynamic parameters are summarized m table 1 The mean age of the patients was 
64 3 (SD 8 7) years and the mean total I-PSS score, the voiding and the filling 
subscores were 17 1 (SD 7 1), 9 8 (SD 4 7) and 7 4 (SD 3 7) When the patients were 
classified according to I-PSS, the mild symptom group included 75 patients, the 
moderate symptom group mcluded 428 patients, and the severe symptom group 
included 300 patients When the patients were classified according to hnPURR, 249 
men had no obstruction The mean total I-PSS score m this group was 15 5 (SD 6 9) 
In 330 men a moderate degree of obstruction was found, they had a mean total I-PSS 
score of 17 1 (SD 6 8) Finally, in 224 patients with a severe degree of obstruction a 
mean total I-PSS score of 18 9 (SD 6 9) was found Because of the large number of 
patients the average symptom scores were significantly different between these groups 
However, the differences are too small and the overlap is too great to be of any clinical 
significance 
Table 1 Baseline characteristics of the clinical parameters and urodynamic parameters 
Age (years) 
Prostate volume (cm3) 
hnPURR 
URA(cmHjO) 
Pdet Q max (cm H20) 
pmuo (cm H20) 
Q max (ml/s) 
Wfmax 
I-PSS total 
I-PSS voiding 
I-PSS filling 
N 
803 
733 
801 
798 
803 
797 
795 
583 
803 
803 
803 
Mean± SD 
64 ± 8 7 
44 ± 22 
36 ±19 
57 ±28 
28 ±18 
11±5 
10±5 
17 1±7 1 
98 ± 4 7 
74 ± 3 7 
Median 
63 8 
38 
2 
32 
52 
24 
10 
9 
17 
10 
7 
Range 
38-89 
13-170 
0 - 6 
2-122 
2-212 
0-114 
1-49 
0 4-53 
0-35 
0-20 
0-15 
N number of patients 
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In table 2, the relationship between different questions of the I-PSS symptom 
score and objective evidence of obstruction is summarized There is a statistical 
significant correlation between all individual I-PSS questions and the objective 
parameters of obstruction, except for question number 3 (intermittency) In descending 
order, the best (but still weak) correlation between linPURR and the I-PSS symptom 
score was found for question 4 (r=0 20), question 7(r=0 15), the quality of life question 
and question 2 (r=0 13), question 6 (r=0 11), question 5 (r=0 09), question 1 (r=0 08) 
and question 3 (r=0 06) The correlation between the total symptom score and pressure 
flow studies are also shown in table 2 The filling component correlated somewhat 
better with the obstruction than the voiding and total symptom score 
Table 2. The Spearman correlation between the results of different I-PSS questions, filling 
component, voiding component and total score with the different urodynamic parameters 
Spearman correlation coefficient 
IPSS1 
IPSS2 
IPSS3 
IPSS4 
IPSS5 
IPSS6 
IPSS7 
IPSSQL 
IPSStot 
filling 
voiding 
Median 
2 
3 
2 
2 
4 
1 
2 
4 
17 
7 
10 
linPURR 
08 
13 
06 (NS) 
20 
09 
11 
15 
13 
18 
21 
12 
URA 
06 (NS) 
12 
06 (NS) 
17 
10 
10 
16 
13 
17 
19 
11 
PdetQmax 
08 
12 
04 (NS) 
22 
09 
10 
13 
12 
17 
21 
11 
pmuo 
10 
13 
05 (NS) 
18 
09 
06 (NS) 
11 
14 
16 
19 
10 
NS = not statistically significant, all other coefficients were statistically significant at p<0 05 
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The relation between the voiding questions and the grade of obstruction are 
shown in the figure 1. There seems to be no clear correlation between these two entities 
which can be of any clinical significance. The relation between filling questions and 
instability is shown in figure 2. There is no correlation between frequency of micturition 
and instability. To the contrary, a significant correlation between urgency and nocturia 
with instability was observed even though it is weak. Finally in figures 3-A and В the 
relation between the obstruction classification and the total symptom score is presented. 
There is a clear shift to more obstruction with more symptoms and vice versa. However, 
again, the overlap is huge which renders the clinical significance of the I-PSS arbitrary. 
• 1 2 1 4 9 1 1 2 3 4 3 
IPSS5 acera τρςςή мог· 
linPURR<2
 α
 linPURR2&3 [—] linPURR>3 
Figure 1. Distribution of grade of BOO (as measured by ¡in PURR) by symptom score for the 
voiding questions of I-PSS (I, 2, 3, and 5). 
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100% 
eos 
I eos 
f 40% 
О stable H instable 
Figure 2. Distribution of instability by symptom score for the filling questions ofl-PSS (2, 4, 
and 7) 
Discussion 
Several indices have been developed over the years to measure the subjective 
symptoms of patients with BPH It is generally accepted that the I-PSS symptom score 
is a reliable and valid instrument to measure severity of symptoms and symptom 
progression over time [15] 
The development of filling and voiding symptoms and the interrelationship 
between bladder function and benign prostatic hyperplasia is complex This complexity 
is due to an incomplete understanding of the pathophysiology of BPH and the exact 
relation between symptoms and bladder outlet obstruction The traditional 
pathophysiological concept is that prostatic enlargement causes bladder outlet 
obstruction which m tum may lead to a symptom 
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100 
80 
£ 6° 
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4: 40 
20 
U !inPURR>3 
NnPURR 2-3 
NnPURR<2 
20-35 
В 
100
 n 
во 
- 60 
* 
ю 
a 
40-
20 
Вп PURR <2 linPURR>3 
Figure 3 A & B- The relation between I-PSS total symptom score classified into mild, 
moderate and severe and BOO quantified by linPURR into mild, moderate and severe. 
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complex, formerly known as 'prostatism' f 16]. Optimally, a symptom questionnaire 
should measure the cause of the complaints. The latter is important in view of the choice 
of therapy. If a patient predominantly has complaints caused by BOO, a more invasive 
approach is recommended while a patient without BOO should be treated otherwise 
117]. Currently, urologists mainly use symptoms as basis for the choice of therapy. 
Thus, the correlation between symptoms and the objective measures of outlet 
obstruction is important 
The aim of this study is to investigate the relationship between the results of 
urodynamic studies and LUTS as measured by the I-PSS symptom score. Earlier studies 
showed no or only a weak correlation between LUTS and BOO 111,12]. Also, in a 
recent article by Rosier et al, the authors found that the symptoms can not differentiate 
between patients with and without urodynamically BOO [18]. A similar result was 
obtained in our study. We found that 31% (249) of our patients were not obstructed 
according to linPURR. This is in accordance with other studies |19]. Although one 
would expect only minimal symptoms in these patients, 31% of them had severe 
symptoms (I-PSStot > 19) (figure 3-B). Although from figure 3-A a trend is observed 
between the grade of BOO and severity of symptoms, the correlation is only weak. 
Consequently, a patient with a given severity of symptoms cannot be identified as being 
obstructed or not. This is clarified in figure 3-B. In 15% of patients with minimal 
symptoms, a severe bladder outlet obstruction can be found while 25% of the patients 
with severe symptoms show no bladder outlet obstruction. For the total I-PSS score the 
correlation coefficient is only r=0.18, (table 2) which is not clinically relevant (the 
explained variance is only . 182 =3%). 
To explain this poor correlation, a more detailed analysis was performed. 
Possibly, certain (groups of) questions would correlate better with outlet obstruction. 
The symptoms associated with BOO due to BPH have been documented for many years 
as obstructive (voiding) and irritative (filling) symptoms. The voiding symptoms arc 
'assumed' to arise as a direct result of obstruction to the prostatic urethra and include 
incomplete emptying of the bladder, intermittency, straining and weak stream. The 
filling symptoms include frequency, urgency and nocturia. These are thought to result 
from detrusor instability which is said to arise secondary to BOO. In contrast to earlier 
studies, filling symptoms correlated better to the grade of bladder outlet obstruction 
than voiding symptoms [20]. The correlation coefficient for the filling symptoms with 
the linPURR classification is r=0.21 compared to only r=0.12 for the voiding 
symptoms. The same applies to the URA classification, PdctQmax and pmuo. More 
detailed information regarding the relation between voiding questions and bladder 
obstruction is summarized in figure 1. In this figure the weak correlation is visualized. 
A similar study was performed regarding filling questions and the presence of bladder 
instability (figure 2). There appears to be no statistically significant correlation between 
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complaint of frequency and bladder instability On the other hand urgency and nocturia 
show a weak correlation with bladder instability How can this be explained? The I-PSS 
symptom score measures only a limited number of symptoms These questions have 
been derived from 'clinical experience and knowledge of BPH' Most probably they 
indeed can quantify the seventy of the symptoms However, they do not correlate with 
the grade of BOO To improve the current questionnaires, the ICS-BPH study was 
initiated [21] The aim of this study is to investigate the relationship between the results 
of urodynamic studies and a wide range of urinary symptoms It is intended that this 
questionnaire is developed so that it may be used in research and clinical practice 
Another approach to obtain information about the presence of BOO without performing 
urodynamic studies with pressure-flow analysis has been studied by Rosier et al [18] 
It appeared that prostate size and the results of uroflowmetry measurements provide 
useful not- urodynamic indicators for the existence of bladder outlet obstruction A 
combination of these investigations has been used to derive a urodynamically validated, 
not invasive, disease specific, clinical prostate score (CLIPS) 
From our study and the results of studies cited above, it must be concluded that 
the symptoms cannot be used to diagnose BOO accurately Therefore, symptoms should 
not be used as a major indication for surgical management Also, on the basis of 
symptoms alone we were unable to define subgroups that may benefit from further 
urodynamic examination Therefore, a better understanding of the pathophysiology of 
lower urinary tract symptoms is needed, for only then we will be able to optimise 
treatment in patients with LUTS and/or BOO 
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Abstract 
Objectives: To evaluate the relation between lower urinary tract symptoms (LUTS) as 
measured by the International Prostate Symptom Score (I-PSS) and non invasive 
objective parameters of lower urinary tract dysfunction. 
Methods: 803 consecutive patients with LUTS and/or BPH were evaluated with I-PSS, 
uroflowmclry, prostate volume estimation and postvoid residue measurement. The 
relations between these parameters were quantified by means of Spearman correlation 
coefficients. 
Results: Statistically significant but weak correlations were found between the I-PSS 
and results of uroflowmetry and postvoid residual urine. There was no correlation 
between the I-PSS symptom score and results of prostate volume measurements. 
Conclusions: The correlation between objective non invasive parameters of lower 
urinary tract dysfunction and lower urinary tract symptoms is only weak. 
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Introduction 
The development of prostatic enlargement secondary to benign prostatic 
hyperplasia (BPH) and the development of lower urinary tract symptoms (LUTS) are 
frequent events in ageing males [1] Most of the patients who seek medical advice do 
so because of bothersome symptoms [2] Consequently, symptoms have become the 
major focus in the management of bladder outlet obstruction (BOO) due to BPH [3] 
Many urologists use the symptoms as the basis for diagnosis of outlet obstruction and 
for assessment of treatment efficacy A number of symptom scores have been designed 
in search of an objective and structured history of symptoms Nowadays, the most 
widely used symptom score is the International Prostate Symptom Score (I-PSS) It is 
generally assumed that the I-PSS symptom score is a reliable and valid instrument to 
measure subjective seventy of symptoms and symptom progression over time [4] 
Besides subjective parameters, changes in objective parameters are used to evaluate 
treatment success Because treatment of BPH usually focusses on BOO, ideally the 
objective parameters quantify the improvement in grade of obstruction Urodynamic 
investigations with pressure-flow analysis are the gold standard to measure grade of 
obstruction Its role m the diagnostic armamentarium of BPH, however, is controversial 
Urodynamic investigations arc invasive and time consuming [5] Moreover, there is a 
large equivocal area m the pressure flow relationship in which"ruhng out" obstruction 
is difficult 
The majority of urologists still use non-invasive objective parameters to 
document obstruction such as urinary flow rate, residual urine and prostate volume 
Uroflowmetry is available almost universally, easy to perform, and probably the most 
frequently used test in urology today [6,7] Uroflow and, especially, maximum flow 
rate (Qmax) are used equivalently with pressure flow studies to define bladder outlet 
obstruction Although uroflow describes the relation between detrusor activity and 
outflow, current opimon holds that if Qmax is lower than 10 ml/s the patient is most 
likely obstructed, whereas he is probably unobstructed if Qmax is higher than 15 ml/s 
[8] Also, prostate size and its changes are especially relevant to the choice of treatment 
that (non) surgically reduce prostatic bulk Common practice dictates that the postvoid 
residual urme determination is a useful objective measurement of the effect of prostatic 
occlusion on the postenor urethra The second international consultation on BPH 
recommended the measurement of postvoid residual unne m the diagnostic workup of 
patients with symptoms of LUTS due to BPH [9] 
Currently no agreement exists among the urologists concerning the minimal 
requirements for diagnosis and follow up of patients with LUTS and/or BPH 
Moreover, the correlation between several of these parameters has been questioned 
The present study was conducted on a large series of patients to evaluate the relation 
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between LUTS, as measured by the I-PSS symptom score, and objective non mvasive 
parameters of lower urinary tract function 
Material and methods 
We studied 803 consecutive patients with LUTS and/or BPH All patients 
included in the present study were subjected to a standardized diagnostic program 
including history (including the I-PSS) (page, 27), physical examination (including 
digital rectal examination), biochemistry (including PSA), urinalysis and culture, urine 
cytology and urodynamic investigations including pressure flow studies Patients with 
a total I-PSS symptom score < 8, 8-19, >19 were considered to have mild, moderate, 
and severe symptoms, respectively [10] The total score of questions 2, 4 and 7 
represents the filling component of the I-PSS symptom score, while the total score of 
questions 1, 3, 5 and 6 represents the voiding component Free uroflowmctry was 
performed m private when the patient presented with normal to severe urge to void 
Flow was measured using a Dantec urodyn 1000 flowmeter According to Abrams and 
Griffiths, a maximum flow rate exceeding 15ml/s generally indicates unobstructed 
micturition, whereas values below 10 ml/s indicate intravesical obstruction, provided 
detrusor insufficiency is absent [8] Patients involved in uroflowmctry studies were 
considered for the study if the voided volume> 150 ml Seventy four patients did not 
fulfil this requirement The data from the remaining 729 patients were used for analysis 
The prostate size was determined using the Kretz combison 330 ultrasound scanner 
with a 7 5 MHZ transrectal probe (multi 3-D VRW 77 AK) The prostate was imaged 
from base to apex, documenting the presence of prostate abnormalities and measuring 
the prostate volume using the planimetrie method [11] The same ultrasound scanner 
was used in combination with a transabdominal probe (Kretz AWP 3 5) for the 
estimation of urine residue directly after performing uroflowmetry 
For statistical analysis we used descriptive statistics and the Spearman 
correlation coefficient (r) to describe the association between I-PSS questions and the 
various tested parameters Comparisons among group of symptom score were made 
using the Kruskal-Walhs test 
Results 
Descriptive statistics with respect to the patients' age, flow results, prostate 
volumes, and postvoid residual unne measurements are summarized in Table 1 The 
mean age of the patients was 63 5 (SD=8 4) years and the mean total I-PSS score, the 
voiding and the filling subscorcs were 17 (SD=7), 9 7 (SD=4 8) and 7 3 (SD=3 4), 
respectively When the patients were classified according to the I-PSS, the mild 
symptom group included 71 patients, the moderate symptom group included 392 
patients, and the severe symptom group included 266 patients There were small but 
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statistically significant differences between I-PSS classes and maximum flow rate and 
residual unne measurement 
Table 1 Result of age, uraflow, prostate volume and postvoid residual urine measurements 
according to three classes of I-PSS -score (mild, moderate and severe) 
I-PSS 
Number 
Age (years) 
Q max (ml/s) 
Pros V (cm3) 
residual (ml) 
IPSS total 
IPSS voiding 
IPSS filling 
All patients 
729 
63 5 ± 8 4 
11 5 ± 5 2 
43 ±20 
48 ±71 
17±70 
9 7 ± 4 8 
7 3 ± 3 4 
Mild 
71 
63 7 ± 8 0 
13 8 ± 7 0 
40 ±20 
44 ±86 
5 ± 1 9 
2 6 ± 1 8 
2 5 ± 1 8 
Moderate 
392 
63 8 ± 8 8 
11 9 ± 5 2 
45 ±21 
41±61 
14 1±3 2 
7 9 ± 2 9 
6 3 ± 2 6 
Severe 
266 
63±7 9 
10 3 ± 4 3 
42±19 
60 ±80 
24 5 ± 3 6 
1 4 4 ± 3 0 
1 0 0 ± 2 4 
In table 2 we correlated the individual I-PSS questions with each of the four 
parameters mentioned above Interestingly, we found only a small correlation between 
the maximum flow rate and weak stream (question 5) The same holds for incomplete 
emptying of the bladder (question 1) and residual unne (r=0 17) Statistically significant 
but weak correlations were also found between all questions of I-PSS and Qmax and 
residual unne, and for prostate volume with questions 4 (urgency), and 5 (weak 
stream) Table 3 represents the correlations among the total I-PSS with its voiding and 
filling components and Qmax, prostate volume, postvoid residues and ages of all 
patients All the tested parameters have a correlation with the total I-PSS symptom 
score except prostate volume Also, the ages of the patients correlated significantly with 
Qmax, prostate volumes and residual urine but not with the total I-PSS However, all 
correlations are small 
The relationships between the grade of total I-PSS symptom score and the 
results of the maximum flow rate are shown in figure 1-A An increase in the seventy 
of symptoms significantly correlates with a decrease in flow rate, but the overlap in flow 
rate between patients with different I-PSS scores is considerable Figures 1 -B and 1 -C 
represent the relationships between postvoid residual urine measurements and prostate 
volumes and the different grade of I-PSS symptom score A weak association exists 
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between the residual unne and different grades of symptoms but no correlation was 
found between prostate volumes and seventy of symptoms 
Table 2. Spearman correlation between the I-PSS questions and non invasive parameters of 
LUTS 
Median 
IPSS1 
IPSS2 
IPSS3 
IPSS4 
IPSS5 
IPSS6 
IPSS7 
Qi 
IPSS total 
IPSS voiding 
IPSS filling 
2 
3 
2 
2 
4 
1 
2 
4 
17 
10 
7 
Age 
0 12 
0 04 (NS) 
0 06 (NS) 
0 06 (NS) 
0 07 
0 08 
0 16 
0 06 (NS) 
0 05 (NS) 
011 
0 06 (NS) 
Qmax 
-0 10 
-0 09 
-0 19 
-0 05 (NS) 
-0 23 
-0 12 
-0 12 
-0 15 
-0 20 
-0 21 
-0 10 
Prostate vol 
0 05 (NS) 
0 05 (NS) 
0 01 (NS) 
0 15 
011 
0 01 (NS) 
0 06 (NS) 
0 04 (NS) 
0 03 (NS) 
0 02 (NS) 
011 
Residue 
0 17 
0 13 
0 09 
0 07 
0 13 
0 14 
0 10 
018 
0 18 
0 17 
0 13 
Discussion 
In the present study we evaluated the relationship between LUTS due to BPH 
as measured by I-PSS and objective non invasive parameters of lower urinary tract 
dysfunction Our study shows that the overall symptom seventy correlates only weakly 
with the results of uroflowmctry and postvoid residual urine measurements Symptom 
seventy does not correlate at all with the prostate volume and ages of the patients The 
weak correlation between symptoms and urinary flow rate was shown before by Barry 
et al [10] However, problems with the urinary flow rate concerning measurement 
errors, systematic learning effect and the main difference between physiological outlet 
obstruction and the symptoms associated with BPH are known [6,7] As illustrated by 
figure 1-A there is a weak association between seventy of symptoms and unnary flow 
rate This supports the hypothesis that the symptoms may originate from 
ncurophysiological changes that may or may not be associated with histological and 
anatomical BPH From that we conclude that for an individual patient, the lack of 
correlation between symptoms and flow rate results should not alter the diagnosis of 
BPH 
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The relationship between prostate volume and parameters for bladder outlet 
obstruction have also been studied by others [12]. In our study, it was shown that no 
correlation exists between the I-PSS symptom score and prostate volume. This lack of 
correlation can be explained as hyperplasia may be associated with striking lateral lobe 
enlargement but symptoms may be negligible if the degree of obstruction is not severe. 
Conversely, BPH may be associated with a relatively small sized prostate and marked 
obstructive symptoms if the obstructing tissue originates exclusively within the central 
zone of periurethral gland areas f 13]. In figure 1-C we demonstrate the absence of any 
relationship between prostate volume and the severity of symptoms. 
Determination of postvoid residual urine provides one of the most effective 
methods of evaluation of patients during a period of watchful waiting and monitoring 
response to treatment. Also, large studies on urodynamic results of surgical treatment 
of BPH have shown that the volumes of residual urine significantly decrease after 
surgery [14]. In our study, we evaluated the relation between postvoiding residual urine 
and a maximum flow rate and severity of symptoms. A statistical significant correlation 
was found between all questions of the I-PSS and residual urine and maximum flow 
rate. However, the clinical significance of this finding is minimal, because there exists 
a huge overlap in symptom score between patients with different grades of BOO 
From the current study we conclude that the correlation between the 
uroflowmetry results, prostate volume, postvoid residual urine and lower urinary tract 
symptoms as measured by the International Prostate Symptoms Score (I-PSS) is only 
weak. Moreover the main problem in the documentation of outcome of treatment of 
BPH consists of achieving agreement in the use of the different parameters. Should we 
aim at improvement of symptoms only, an improvement of the objective voiding 
parameters, or even an improvement of both? 
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Table 3. Spearman correlations between total I-PSS, its voiding and filling components and 
patients ' ages, uroflowmetry results, prostate volumes andpostvoid residues 
Age I-PSS I-PSSvoid I-PSSfillmg Qmax Pros Vol 
I-PSS 0 05 (NS) 
I-PSS void Oi l 0 89 
I-PSS filling 0 06 (NS) 0 78 
Qmax -0 17 -0 20 
Prostat vol 0 34 0 03 (NS) 
Residue 0 10 0 18 
0 45 
-0 21 
0 03 (NS) 
0 17 
-0 10 
011 
0 Π 
-0 07 
-0 17 0 12 
100 
Mild 
I | Qmax >15 
g 3 Qmax 10-15 
• Qmax<10 
Severe 
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Figure 1- The severity of symptoms according to three classes (mild <8, moderate=8-19, and 
severe >19) and-
A-the distribution ofQmax classified into 3 classes (less than lOml/sJO-
15ml/s, and more thanlSml/s). 
B-the distribution ofpostvoid residues classified into 3 classes (less than 
50 ml, 50ml-lÛ0ml, and more than 100 ml). 
C-the distribution of prostate volume into 3 classes (less than 30 cm3, 30-
70 cm3 , and more than 70cm3). 
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Introduction 
The rapidly rising numbers of the elderly male population all over the world 
lend increased urgency to the current debate as to appropriate treatments for benign 
prostatic hyperplasia (BPH). Because it was generally accepted that the prostate gland 
is responsible for lower urinary tract symptoms (LUTS) in these men, most available 
therapies focussed on treatment of the adenomatous prostate tissue. Transurethral 
prostatectomy (TURP) has become well established as the standard technique for the 
vast majority of glands [1]. Following the introduction of minimal invasive treatments, 
e.g., prostatic stents [2] and balloon dilatation [3], medical treatment [4] was used in 
the treatment of these patients. Encouraged by their early results many other techniques 
have been introduced and applied in patients with LUTS: transurethral needle ablation 
of the prostate using a radiofrequency device (TUNA) [5], transurethral microwave 
thermotherapy (TUMT) [6], high intensity focused ultrasound (HIFU) [7], several laser 
delivery systems [8] and most recently, a tissue vaporization technique using electrical 
current with a modified rollerbal called Vaportrode [9]. 
The introduction of effective alternative treatments for BPH and the growing 
number of relatively non-invasive treatments may suggest that it can be cured more 
easily than previously. These developments, in combination with changes in the social 
habits and increasing life expectancy may have some effects on the number of patients 
presenting with symptoms possibly related to BPH. Consequently the costs involved in 
the assessment increase rapidly and however, authorities stress to use available 
resources wisely. As we move into an era where alternatives to surgery are increasingly 
used in the treatment of BPH, the time has come to consider the minimum diagnostic 
criteria that should be established before any treatment. This review is a critical 
evaluation of the current clinical diagnostic techniques used in the assessment of BPH, 
in an attempt to define the values and to specify their position in a practical diagnostic 
way. The diagnostic tests currently used will be discussed under the following headings: 
1) symptom scores, 2) urinalysis, 3) imaging of the upper urinary tract, 4) transrectal 
ultrasound of the prostate, 5) cystoscopy, 6) voiding studies. Finally we will provide 
recommendations concerning the use of diagnostic tests in the assessment of patients 
with LUTS. 
Symptom scores 
Many urologists use the symptoms as the basis for diagnosis of outlet 
obstruction and for evaluation of treatment success. Most of the symptom scores have 
been designed to permit more objective and structured history of symptoms in patients 
with lower urinary tract symptoms (LUTS) and/or BPH. There are several advantages 
of having a common symptom score, such as for use in assessing the efficacy of 
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treatment of BPH and to simplify the comparison of the outcomes of different treatment 
modalities conducted at different sites and at different times [10] Boyarski [11J was 
among others the first to develop such a score, followed by Madsen & Iversen [12], and 
Fowler [13] In 1992 the A U A symptom score was published and this has been 
adopted by the World Health Organization as International Prostate Symptom Score (I-
PSS) [14] It has been integrated into the evaluation of patients with LUTS and has 
been recommended as a precise tool to be used in the diagnosis of these patients [15] 
On the other hand, little is known about the natural history of patients with BPH, but 
it appears that the course is not necessarily one of deterioration A considerable fraction 
of patients may show spontaneous improvement or stabilization of symptoms 116] 
Also, individual perception about seventy of disease may vary It is therefore justified 
to question whether the clinician dealing with individual patients can rely on one 
measurement of I-PSS to determine the management of the patient and to recommend 
therapy Moreover, to rely on the use of such a questionnaire, evaluating the test's 
reliability is mandatory In one of the key articles from Barry et al [17] it was pointed 
out that the measurement reliability can be increased by basing decisions on the mean 
of 2 or more measurements on the same patient In a recent study by Ezz El Din et al 71 
patients were studies at an interval of 8 weeks [18] From this study it was clearly 
shown that at such an interval a significant variability in the IPS S score can be found 
One forth of all tested patients did not comply any more with the inclusion criteria for 
treatment, which are used at our department This is a considerable number of patients 
and therefore we think that the decision to treat or not to treat, using the symptom score 
as the "sole" criterion, should be made at an interval of 8 weeks If a similar 
recommendation for the IPSS score should be given at the follow up cannot be answered 
from that study 
Conclusion keeping the variability of the IPSS score in mind when making the 
decisions concerning treatment of patients with LUTS and/or BPH is important 
Urinalysis 
One of the most frequent performed tests in urology is a urinalysis, and the 
WHO recommends urinalysis as a standard to perform in the assessment of BPH [19] 
Besides the presence of leucocytes during microscopy, especially the presence of 
microhaematuna seems to be of major importance However, most physicians are often 
unsure as to how aggressively to pursue urologie evaluation of a patient with 
microhaematuna On one hand, it is suggested that this test is relatively inexpensive and 
that in older men with BPH the benefits of such a test as this clearly overweigh the harm 
involved The commonest abnormalities of hacmatuna in the BPH age group are 
bladder carcinoma, renal cell carcinoma, urinary calculi and acute urinary tract infection 
1201 Glomular causes are indicated if red blood cell casts arc found in the unnary 
sediment or if RBCs are of abnormal morphology Several studies showed that 
по 
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microhaematuria was a common finding, occurring in 13% of the population [20, 21 J. 
Messing et al concluded from their work that the positive predictive value of this finding 
was 26% [21]. On the other hand Sandler et al found that routine urinalysis contributed 
little useful information and deplored the consequent waste of money [22]. Because of 
this contradicting findings, we have evaluated a group of 750 patients because of 
symptomatic BPH, to determine the additional value of the presence of microscopic 
hacmaturia in these patients [23]. It appeared that haematuria was found in one third of 
the patients. Only 3 had a bladder tumour and there appeared to be no correlation 
between the grade of haematuria and the finding of urothelial cancer. Also 49 had 
urinary calculi for which only one patient required treatment. Therefore a plain 
abdominal X ray is not to be recommended in patients with BPH and voiding 
complaints because the outcome does not change the treatment policy and should only 
be performed in the presence of upper urinary tract complaints. Moreover, there was no 
correlation between any other clinical parameter and the finding of microscopic 
haematuria. 
Conclusion: microscopic haematuria is a frequent finding in the assessment of BPH 
patients and additional tests should only be performed if indicated. 
Imaging of the upper urinary tract 
Until the early eighties an IVU prior to treatment of BPH was advocated as a 
first choice method of screening the (upper) urinary tract. Several studies however 
demonstrated that 73 to 92% of the patients with LUTS have a normal IVU, 
hydronephrosis being the most common reported abnormality in 3 to 13% of the cases 
[24, 25]. Because hydronephrosis may cause renal impairment, this finding can 
influence the treatment approach and therefore hydronephrosis is obviously the most 
important condition to be excluded. This and the fact that urography involves radiation 
exposure and a risk of possible allergic reactions to intravenous contrast material [26], 
rises the question for the necessity of urography in uncomplicated BPH. Matthews et 
al elegantly demonstrated that ultrasonography could very well replace IVU to detect 
most abnormalities in uncomplicated cases [25]. Lilienfeld went even one step further 
and suggested replacement of the IVU for the combination of renal ultrasound, plain 
abdominal X-ray, urinalysis and blood urea nitrogen determination [27]. Because of 
these reports we decided to evaluate the efficacy of a standard transabdominal 
ultrasound investigation of the kidneys prior to treatment of BPH [28]. In 2.5% a 
dilatation of the renal pelvis was found, in 11.7% renal cysts, and 0.2% patient had a 
renal cell carcinoma. Performing ultrasonography of the kidneys as a standard imaging 
procedure in all patients would mean an unrewarding investigation in the vast majority 
of cases. Criteria for selecting patients for renal ultrasound are needed to limit the 
number of ultrasounds and subsequently reducing costs without taking the risk of 
missing clinically relevant pathology of the upper urinary tract. Analysis of parameters 
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used in the assessment of patients with BPH showed that the result of serum creatinine 
may be used as an indicator for renal impairment and could be a useful selection 
criterion for performing renal ultrasound By adding the result of the post voiding 
residual to the outcome of the serum creatinine level even improved the decision making 
of performing a renal ultrasound Only one patient with a renal malignancy would be 
missed when using the proposed entena We feel however, that the incidental finding 
of renal cancer docs not justify the performance of a renal ultrasound to exclude upper 
urinary tract pathology in all patients with uncomplicated BPH Moreover, in view of 
the results of this study we think that there is only limited use for performing an IVU 
Conclusion Renal ultrasound to exclude upper unnary tract pathology m patients with 
bladder outlet obstruction and BPH will only give additional information if the serum 
creatinine is higher than 130 μπιοΙΛ Incase of a serum creatinine between 115 and 130 
цтоі/і a renal ultrasound is advocated if a post void residual volume larger than 150 ml 
or bladder retention is present In all other patients we advise that the renal ultrasound 
is not mandatory 
Transrectal ultrasound of the prostate 
Transrectal ultrasound (TRUS) of the prostate is a rapidly advancing modality 
with growing acceptance and importance for diagnosis and management of prostatic 
diseases Since its clinical application in 1971 by Watanabe, TRUS has now developed 
into a sophisticated technology [29] TRUS is unmatched as an imaging modality 
because of its versatility, ease of application and cost effectiveness TRUS can, among 
others, be applied to estimate the prostate volume, to diagnose prostate cancer, and as 
a guidance to perform prostate biopsies The estimation of the prostate volume is one 
of the most frequently performed tests during TRUS and may be useful in a variety of 
ways A precise estimate of the amount of benign prostatic hyperplasia would help to 
decide the appropnate therapy and assists m the interpretation of serum prostate 
specific antigen level for the presence of cancer The three most commonly used 
methods for estimation of the size of the prostate are the planimetrie method, the 
method using the three dimensions of the prostate, and the ellipsoid method [30] To 
overcome inaccuracy m the volume measurements, an automated method for volume 
determination has been investigated at our department [31 ] This method is based on 
planimetrie volumetry to overcome subjectivity in prostate volume measurements using 
ultrasonography Moreover, this method is a useful tool m the objective determination 
of the prostate specific antigen m proportion to the volume [32] 
Conclusion transrectal ultrasound is unmatched as an imaging modality because of its 
versatility, ease of application and cost effectiveness 
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Cystoscopy 
Urethrocystoscopy gives information as to the cause, seventy of obstruction, 
patency of the bladder neck, prostatic occlusion of the urethra and the estimated 
prostatic size [33] Many urologists try to evaluate the degree of obstruction by 
assessing bladder trabeculation Turner-Warwick et al concluded that the endoscopic 
appearance of trabeculation in men is usually associated with a thick walled bladder but 
is not diagnostic for obstruction, their commonest correlation is with unstable detrusor 
function that may or may not be associated with obstruction [34] Andersen and 
Nordling concluded in their study that urethrocystoscopy gives good information of the 
site and seventy of the obstruction [35] In a more recent paper Madsen and Bruskewitz 
concluded that urethrocystoscopy has a limited role in the evaluation of BPH It is 
mentioned, however, that available data suggest that bladder trabeculation in BPH is a 
predictor of the treatment outcome Cystoscopy might be performed pnor to invasive 
therapy to guide the urologist in choosing an operative approach [36] Although the 
diagnosis and treatment of BPH is a common subject, only limited information is 
available regarding the correlation between urethroscopic findings and urodynamic 
studies [37] We conducted a study on a large series of patients to evaluate the findings 
of urethrocyslocopy with the results of urodynamic studies in elderly men with voiding 
complaints [38] A significant correlation was found between bladder trabeculation and 
grade of bladder outlet obstruction Detrusor instability correlated significantly with the 
grade of trabeculation The grade of obstruction showed a clear correlation with 
prostatic occlusion of the urethra and the presence of middle lobe at cystoscopy The 
implementation of our findings is useful for daily clinical practices that because a 
considerable number of urologists depend on cystoscopic findings in the diagnosis 
bladder outlet obstruction rather than on urodynamic findings, because they do not have 
urodynamic equipment at their disposal, or are not used to perform urodynamics in 
patients with BPH However, for the individual patient with normal cystoscopic 
findings, bladder outlet obstruction is still present m about 15% of patients On the 
other hand, if severe trabeculation is present, about 8% of patients are not obstructed 
at all 
Conclusion generally the findings at urethrocystoscopy correlate well with the findings 
at urodynamic investigations 
Voiding studies 
It is a central concept in urology that BPH causes prostatic enlargement, which 
in turn may lead to BOO and development of LUTS Therefore, clinical BPH has been 
characterized by the combination of three parameters the presence of lower urinary 
tract symptoms (LUTS), the presence of bladder outlet obstruction (BOO) and 
increased prostate volume due to hyperplasia [39] Urodynamic investigations with 
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pressure-flow analysis are the gold standard to measure grade of obstruction Its role 
in the diagnostic armamentarium of BPH, however, is controversial Urodynamic 
investigations are invasive and time consuming [40] Moreover, there is a large 
equivocal area m the pressure flow relationship in which'Yuhng out" obstruction is 
difficult Despite an increasing number of publications on the relationship between 
LUTS and BOO, the correlation between the two remains unproven [41, 42] Most 
urologists agree that only patients with BOO should be treated by surgical intervention 
Nevertheless, the decision for surgical management is usually based primarily on the 
nature and seventy of presenting symptoms The relationship between symptoms and 
BOO is therefore an important issue We conducted a study on a large series of patients 
with LUTS aiming to delineate the relation between preoperative voiding symptoms 
using the I-PSS symptom score and urodynamic findings [43] A statistical significant 
correlation was found between all questions of I-PSS (except intermittency) and 
objective parameters of obstruction However, the clinical significance of this finding 
is minimal, because there exists a huge overlap of symptom score between patients with 
different grades of BOO The filling component of the I-PSS symptom score correlated 
somewhat better with obstruction than the voiding component From our study it must 
be concluded that the symptoms cannot be used to diagnose BOO accurately Therefore, 
symptoms should not be used as a major indication for surgical management Also, on 
the basis of symptoms alone we were unable to define subgroups that may benefit from 
further urodynamic examination The majority of urologists however, still use instead 
of urodynamic with pressure flow analysis, non-invasive objective parameters to 
document obstruction such as urinary flow rate, residual urine and prostate volume 
Uroflowmetry is available almost universally, easy to perform, and probably the most 
frequently used test in urology today [44,45] Uroflow and, especially Qmax arc used 
equivalently with pressure flow studies to define bladder outlet obstruction Although 
uroflow desenbes the relation between detrusor and outflow, current opinion holds that 
if Qmax is lower than 10 ml/s the patient is most likely obstructed, whereas he is 
probably unobstructed if Qmax is higher than 15ml/s [46] Also, prostate size and its 
changes are especially relevant to the choice of treatment that (non) surgically reduce 
prostatic bulk Common practice dictates that the post voiding residual urine 
determination is a useful objective measurement of the effect of prostatic occlusion on 
the posterior urethra The second international consultation on BPH committee 
recommended the measurement of postvoid residual unne m the diagnostic workup of 
patients with symptoms of LUTS due to BPH [19] 
As pointed before no agreement exists among the urologists concerning the 
minimal requirements for diagnosis and follow up of patients with LUTS and/or BPH 
Moreover, the correlation between several of these parameters has been questioned So, 
we conducted a study on a large scries of patients to evaluate the relation between 
LUTS, as measured by the I-PSS symptom score, and objective non invasive parameters 
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of lower urinary tract function [47] Statistically significant but weak correlations were 
found between the I-PSS and results of uroflowmetry and postvoidmg residual urine 
There was no correlation between the I-PSS symptom score and results of prostate 
volume measurements 
Conclusion From symptoms alone, diagnosing BOO seems impossible Also, the 
correlation between objective non invasive parameters of lower urinary tract dysfunction 
and lower urinary tract symptoms is only weak 
Recommendations 
We recommend that at the baseline preferably two I-PSS scores should be taken and the 
second score to be used as baseline In case of significant difference in scores, may be, 
a third I-PSS score should be taken at 8-weeks interval before deciding to treat or not 
to treat From our studies we have learned that microscopic haematuna is frequently 
diagnosed in patients with benign prostatic hyperplasia and additional tests should only 
be performed if indicated Also, we recommend renal ultrasound in patients with serum 
creatinine higher than 115 and post void residual volume greater than 150 ml or 
bladder retention is present In all other patients we advise that renal ultrasound is not 
mandatory A plam abdominal X-ray is not to be recommended in patients with BPH 
and voiding complaints because the outcome docs not change the treatment policy and 
should only be performed in the presence of upper urinary tract complaints For 
urologists who depend on cystoscopy in diagnosis of BPH, generally the findings at 
urethrocysloscopy correlate well with the findings at urodynamic investigations From 
our results and others, it must be concluded that the symptoms cannot be used to 
diagnose BOO accurately Therefore, symptoms should not be used as a major 
indication for surgical management Also, on the basis of symptoms alone it seems 
impossible to define subgroups that may benefit from further urodynamic examination 
Considerations 
We have learned that a considerable discrepancy exists between LUTS and anatomical 
and physiological measures of obstruction Nowadays, there is a discussion about the 
treatment of BPH Should we mainly aim at treating symptoms, BOO or both? We think 
that depending on the type and nature of the treatment, the diagnostic tests should be 
done The minimal requirements for the clinical diagnosis of BPH are based upon 
careful history taking with quantification of symptoms using the I-PSS, digital rectal 
examination (DRE), urinalysis, serum creatinine, uroflowmetry and post voiding 
residual urme TRUS and assessing prostate size are recommended in cases of suspicion 
for prostate cancer or if the treatment requires estimation of the prostate size 
Urodynamic investigation is recommended in cases of instrumental treatment or if the 
patients do not respond to symptomatic medical treatment 
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Can information about the presence of BOO be obtained without performing 
invasive urodynamic studies7 Tbs has been studied at our department and it appeared 
that prostate size and the results of uroflowmetry measurements provide useful non-
urodynamic indicators for the existence of bladder outlet obstruction A combination 
of these investigations has been used to derive a urodynamically validated, not invasive, 
disease specific, clinical prostate score (CLIPS) [48] 
The outcome of treatment of patients with LUTS is closely linked with the 
making of proper diagnosis Therefore, prior to any treatment we should be aware of the 
cause of the complaints Arc these predominantly originated by BOO or poor bladder 
quality^ These findings are important before deciding the choice of treatment It seems 
that the pathophysiology of lower urinary tract dysfunction is one of the key parameters 
to answer these questions Therefore, a better understanding of the pathophysiology of 
lower urinary tract symptoms is needed, for only then we will be able to optimize 
treatment in patients with LUTS and/or BOO 
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Summary 
In view of the medical and financial impact of making the diagnosis and 
performing treatment of benign prostatic hyperplasia (BPH), the time has come to 
consider the minimum diagnostic entena that should be established before any 
treatment This study is a cntical evaluation of the current clinical diagnostic techniques 
used m the assessment of BPH, in an attempt to define the values and to specify their 
position in a practical diagnostic way 
The most commonly used symptom score in patients with lower unnary tract 
symptoms (LUTS) and/or BPH is the International Prostate Symptom Score (I-PSS) 
Therefore, in chapter 2, we studied the reliability of this symptom score Also, we tried 
to answer the question whether the clinician dealing with individual patients can rely on 
one measurement of I-PSS to decide the management of the patients and to recommend 
therapy We concluded that it is important to keep the variability of the IPSS score in 
mind when making decisions concerning treatment of patients with LUTS and/or BPH 
Nowadays, the urinalysis has become accepted as an essential part of clinical 
assessment of elderly men with BPH Because microscopic haematuna is a common 
finding in patients with BPH, mis may result in a considerable number of investigations 
making the assessment in these patients unnecessanly expensive In chapter 3, we 
conducted a study to evaluate the importance of the presence of microscopic haematuna 
in patients with BPH We found that microscopic haematuna is a frequent finding in the 
assessment of BPH patients and additional tests should only be performed if indicated 
A common method to estimate prostatic obstruction is the measurement of the 
prostate size using transrectal ultrasound So how do the findings at transrectal 
ultrasound of the prostate correlate with the clinical findings'7 We studied in chapter 4 
the value of transrectal ultrasound in evaluation of benign prostatic hyperplasia and in 
other prostatic diseases Transrectal ultrasound is unmatched as an imaging modality 
because of its versatility, ease of application and cost effectiveness 
Another investigation frequently performed in the evaluation of patients with 
BPH is imaging of the upper urinary tract either by sonography of the kidney and a 
plain-X ray of the abdomen or intra venous urography (IVU) alone We correlated in 
chapter 5 the results obtained during renal ultrasonography with other clinical 
parameters and provided recommendations for the indications of performing a renal 
ultrasound in patients with BPH We concluded that renal ultrasound is only indicated 
in patients with a certain creatinine level and/or post voiding residual measurement 
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Urethrocystoscopy is still used by a considerable number of urologists in the 
diagnosis of bladder outlet obstruction (BOO) rather than urodynamic investigation 
During urethrocystoscopy malignant diseases of the bladder, bladder stones and other 
abnormalities of the lower urinary tract can be investigated In chapter 6, we correlated 
anatomical findings of obstruction using urethrocystoscopy with the physiological 
measurements of obstruction using urodynamic investigations with pressure-flow 
studies We concluded that the findings at urethrocystoscopy correlate well with the 
findings at urodynamic investigations 
Because most urologists agree that only patients with BOO should be treated 
by surgical intervention and still the decision for surgical treatment is usually based on 
the nature and seventy of symptoms, in chapter 7, we studied the relation between 
LUTS and urodynamic investigation with pressure flow analysis Although urodynamic 
investigation with pressure flow analysis is the gold standard in diagnosis of BOO, 
other less mvasive parameters are used like uroflow, prostate volume and postvoid 
residual measurements In chapter 8, we correlated the LUTS and non invasive 
parameters of obstruction including uroflowmetry results, prostate volumes and 
postvoid residual urine measurements We concluded that from symptoms alone, 
diagnosing BOO seems impossible Also, the correlation between objective non 
invasive parameters of lower urinary tract dysfunction and lower urinary tract symptoms 
is only weak Finally in chapter 9, we give an overview on the most important 
recommendations concerning evaluation of patients with BPH 
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Samenvatting 
Gezien de medische en financiële impact van de diagnostiek en behandeling van benigne 
prostaat hypcrplasie (BPH), is het aan de tijd om de diagnostische criteria te bepalen die 
vereist zijn alvorens tot behandeling over te gaan. De hier gepresenteerde studie is een 
kritische evaluatie van de huidig beschikbare klinische technieken voor het 
diagnostiseren van BPH, in een poging om hun waarde te evalueren en hun positie weer 
te geven op een practische diagnostische wijze. 
De Internationale Prostaat Symptoom Score (I-PSS) is de meest gebruikte symptoom 
score voor patiënten met klachten gerelateerd aan de lagere urine wegen en/of BPH. In 
hoofdstuk 2 wordt de betrouwbaarheid van deze symptoom score geëvalueerd. 
Daarnaast is ook getracht een antwoord te vinden op de vraag of de onderzoeker bij de 
individuele patient kan vertrouwen op het resultaat van een enkele meting van de I-PSS 
alvorens tot behandeling over te gaan. Wij concludeerden dat de variabiliteit van de I-
PSS moet worden meegenomen in de beslissingen omtrent behandeling van symptomen 
van de lagere urineweg en/of BPH. 
Hedentendage is een analyse van de urine algemeen geaccepteerd als essentieel 
onderdeel van het klinisch onderzoek van oudere mannen met BPH. Microscopische 
haematurie wordt vaak aangetroffen in patiënten met BPH, hetgeen kan resulteren in een 
groot aantal onderzoekingen die tot onnodige kosten kunnen leiden. In hoofdstuk 3 
wordt een studie beschreven waarbij gekeken is naar het belang van de aanwezigheid 
van microscopische haematurie bij BPH patiënten. Het bleek dat microscopische 
haematurie veelvuldig wordt gevonden bij onderzoek van BPH patiënten en dat 
additioneel onderzoek alleen moet worden uitgevoerd als verwacht mag worden dat de 
haematurie veroorzaakt wordt door andere klachten dan BPH. 
Prostaatvolumemeting met transrectal echografie is een veelgebruikte methode voor 
het bepalen van de ernst van de prostaat obstructie. Welke is nu de correlatie tussen de 
resultaten van transrectale echografie van de prostaat en de klinische bevindingen? In 
hoofdstuk 4 hebben we de waarde van transrectal echografie bij evaluatie van BPH en 
andere prostaat aandoeningen bestudeerd. Als beeldvormende techniek bij prostaat 
onderzoek, is transrectale echografie ongeëvenaard vanwege de flexibiliteit, 
gebruikersvriendelijkheid en het gunstige kostenaspect. Daarnaast wordt ook meestal 
beeldvorming van de hogere urinewegen met behulp van nierechografie, een 
buikoverzichtsfoto, of intra veneuze urografie toegepast bij de evaluatie van BPH 
patiënten. In hoofdstuk 5 zijn de resultaten van nierechografie gecorreleerd aan de 
klinische parameters en worden aanbevelingen gedaan omtrent het toepassen van 
nierechografie bij BPH patiënten. Wij concludeerden dat nierechografie alleen 
geïndiceerd is bij patiënten met een zekere creatinine waarde en/of bepaald residu na 
mictie. 
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Bij de diagnose van blaasuitgangsobstructie wordt nog steeds frequent gebruik gemaakt 
van urethrocystoscopie boven een urodynamisch onderzoek. Gedurende 
urethrocystoscopic kunnen bovendien kwaadaardige afwijkingen in de blaas, 
blaasstenen en andere aandoeningen aan de lagere urine wegen worden onderzocht. In 
hoofdstuk 6 zijn de anatomische bevinden van obstructie tijdens urethrocystoscopic 
vergeleken met de fysiologisch obstructiemeting tijdens urodynamisch onderzoek met 
blaasdrukmeting tijdens de mictie. De bevindingen tijdens urethrocystoscopie bleken 
goed te correleren met de urodynamische bevindingen. 
Omdat de meeste urologen de opvatting delen dat alleen patiënten met 
blaasuitgangsobstructie chirurgisch behandeld moeten worden, terwijl de beslissing 
omtrent chirurgisch ingrijpen vaak gebaseerd is op de aard en ernst van de symptomen, 
is in hoofdstuk 7 de relatie onderzocht tussen symptomen van de lagere urineweg en 
urodynamisch onderzoek met blaasdrukmeting tijdens de mictie. Hoewel urodynamisch 
onderzoek algemeen geldt als gouden standaard voor de diagnose van 
blaasuitgangsobstructie, worden vaak minder-invasieve parameters als maximale 
plasstraal, prostaatvolume, en achtergebleven hoeveelheid urine na mictie aangehouden. 
In hoofdstuk 8 zijn de symptomen van de lagere urineweg gecorreleerd aan niet-
invasieve parameters voor obstructiebcpaling zoals resultaten van plasstraalmeting, 
prostaatvolumemeting, en urine residu meting. Hieruit blijkt dat de diagnose 
blaasuitgangs-obstructic niet gesteld kan worden op basis van symptomen alleen. 
Daarnaast was de correlatie tussen lagere urineweg disfunctie en lagere urineweg 
symptomen gering. Tot slot wordt in hoofdstuk 9 een overzicht gepresenteerd van de 
belangrijkste aanbevelingen met betrekking tot het evalueren van patiënten met BPH. 
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behorende bij het proefschrift 
BENIGN PROSTATIC HYPERPLASIA 
CLINICAL ASSESSMENT AND EVALUATION 
van Khaled Ezz El Din 
Nijmegen, 24 Juni 1996 
1 Benign prostatic hyperplasia (BPH) is the most common benign neoplasm in 
the aging male It is estimated that one out of four men in the United States 
will require treatment for the relief of symptomatic BPH by age of 80 
2 The International Prostate Symptom Score (I-PSS) should be used for 
quantification of symptoms and periodically for follow up Moreover, one 
must keep in mind the variability of the I-PSS when making decisions 
concerning treatment. (This thesis) 
3 Imaging of upper urinary tract by plain abdominal X-ray or renal 
ultrasonography is not recommended for the typical patient with benign 
prostatic hyperplasia (BPH) (This thesis) 
4 In patients with BPH, generally the findings at urethrocystoscopy correlate 
well with the results of urodynamic investigations (This thesis) 
5 Symptoms cannot be used for diagnosis of bladder outlet obstruction due to 
BPH, or even to define subgroups of patients that may benefit from further 
urodynamic investigations (This thesis) 
6 The finding of weak correlations between I-PSS symptom score and 
urodynamic investigations implies that we are not always operating for 
obstruction (thesis) 
7 Postvoid residual urine and prostate volume measurements have not been 
proven useful in predicting the outcome of urodynamic investigation (This 
thesis) 
8 The longest journey begins with a single step 
9 Truth cannot be found by aspiring excessively after honor and great wisdom 
but only with fantasy of life 
10 -<5p The sacred eye of horus "Udjat", believed to ward off evil and illness in 
ancient Egypt The belief died, but the eye of Hours persisted as a symbol of 
healing It is the historical source of symbol R/ still used by doctors 
everywhere when writing a prescription 
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